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Abstract
This project involves the design and implementation of a platform to investigate
the activation state of platelets. The final aim is to develop an assay to be used
for diagnostic purposes.
Blood platelets play a key role in the cardiovascular system. When the en-
dothelium of the vessel wall is damaged platelets adhere and become activated,
leading to platelet aggregation to maintain physiological haemostasis. Any abnor-
mality in platelet functionality induces thrombus or atherosclerotic plaques leading
to life-threatening consequences such as stroke. Recent reports suggest that the
detection of activated platelets in the blood may be a useful indicator of the on-
set of stroke and other cardiovascular abnormalities. Hence, the detection of the
functional state of platelets is of huge clinical importance.
A luminescence-based platelet bio-assay which uses high brightness silica nanopar-
ticles (NPs) as super-bright labels is an innovative and promising tool for diagnos-
tics. Compared to assays carried out using conventional single molecule dye labels,
the usage of NPs makes it possible to enhance the detection efficiency of the assay
and to achieve a reduced limit-of-detection. In this work NPs doped with a near
infra-red dye are synthesized and their interactions with the platelets are charac-
terized. Protocols of conjugation of antibodies towards platelet surface antigens
to NPs are tested.
The second part of the work studies the activation state and the morphology
of platelets in different environments by using single molecule dye label assays and
with AFM. The confinement of platelets in micrometer sized area using a protein
patterning technique makes the analysis innovative and potentially very useful.
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Chapter 1
Introduction and background
1.1 Nanoparticles as fluorescent probes
The application of fluorescence is central to many fields. The nanoscale world
is ideally investigated with fluorescent materials. Fluorescence analysis has in fact
high signal-to-noise ratios, a good spatial resolution which is just limited by the
diffraction of the light, and an excellent temporal resolution on the scale of the
fluorescence processes (typically nanoseconds).
The progress of science with its applications requires the development of new ro-
bust and bright materials. Fluorescent emitters/probes being in use nowadays be-
long to different classes of materials, examples of these are shown in figure 1.1. The
Figure 1.1: Common fluorescent probes in the nanoscale range. Ref: [1].
smallest probes are single dye molecules (≈1 nm). Different dyes can be synthe-
sized with different absorption and emission proprieties, with emissions spanning
from UV to near infra-red. They are widely used in the biological applications be-
cause of their small size and consequent hypothetical minimal interaction with the
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system. However, the small size of single molecules affects the labelling efficiency
with relative high background signals arising from non-specific labelling due to the
easy diffusion of the dye away from its target [1]. Moreover single dyes molecules
are not protected from the surrounding environment and can undergo quenching
upon interactions or collisions with other molecules like solvent molecules, oxygen
and ions [2]. The fluorescent emitters of this category are generally not very bright.
Nanoparticles (NPs) are more robust and stable emitters/probes. NPs enclose
thousands of dye molecules in a matrix, therefore protecting the dye from external
interactions with the solvent [3]. When dye molecules are encapsulated inside a
chemically and mechanically stable vehicle, the dye has an increased photostability
[4]. By embedding fluorescent molecules inside a matrix, because of thousands of
dye molecules encapsulated within each NP,a high signal amplification is achieved.
Compared to the use of a single molecule label fluorescence signal is enhanced and
signal-to-noise ratio is reduced [5].
A particle is defined as NP if its diameter is ≤100 nm. For objects in this
scale the number of atoms at the surface is significant relative to the total number
of atoms of the material. In fact, size-dependent properties happen on the nano-
scale, e.g. surface plasmon resonance for some metal NPs or supermagnetism for
magnetics NPs [6].
Additionally, NPs can be suspended in a solvent with no sedimentation or floating
due to the strong interaction of the NP surface with the solvent.
1.1.1 Use of nanoparticles in bioassays
NPs can be used in many biological and biomedical fields, such as sensors,
fluorescent markers for in vitro and in vivo analysis, clinical diagnostic tools, drug
delivery, and MRI contrast agents. The synthesis materials and methods are chosen
according to the target application.
To cite just some of the interesting examples that can be found in the literature,
superparamagnetic ferrite NPs can be used to remotely control neurons. Herein,
a specific surface modification allows to target the cells of interest, and the use
of a radio-frequency magnetic field heats the NPs, thermally activating the ion
channels [7]. Magnetic NPs can be used also as drug carriers against tumor cells.
A tumoral drug is bound to the NP surface, and the NPs are kept in the tumor re-
gion by the use of a magnetic field [8]. Semiconductor nanocrystals (quantum dots)
can be used for tissue microscopy. These are bright and photostable fluorophores
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having the property of quantum confinement. Quantum dots have a broad exci-
tation spectrum but a narrow Gaussian emission at wavelengths controllable by
the size of the material. Larson and others have shown how they can be used in
multiphoton imaging of the blood stream instead of the common fluorophores used
in angiography, simply with an appropriate surface functionalization with water-
soluble ligands [9]. Noble metal NPs, gold especially, also plays an important role
in current research, because of their unique optical properties arising from localized
surface plasmon resonance. Plasmon waves create strong enhancement and spa-
tial confinement of the electromagnetic field around the metallic NPs that plays a
key role in surface-enhanced Raman spectroscopy and metal enhanced fluorescence
[10]. El-Sayed and others have shown that gold NPs can be used in oral cancer
diagnostics by conjugating them with a specific antibody [11].
Silica NPs are extensively used for biological applications due to their bio-
compatibility and low toxicity [12]. Moreover the surface of silica can be easily
functionalized with well known chemistry techniques. Chemically modifying the
silica surface with the addition of functional groups makes it possible to covalently
conjugate the NPs to an antibody, allowing the targeting of a specific type of cell,
as shown by Zhao and others in an assay for quantification of pathogenic bacteria
[13]. Silica NPs are also widely used for intercellular targeting, sensing and drug
delivery. A few examples include the labelling of a variety of different cells using
mesoporous silica fluorescent NPs, from Lin and others [14], and the delivery of
genetic material in tumoral cells using silica NPs conjugated with DNA fragments,
that get released into the cytoplasm and consequently migrate into the nucleus
with consequent protein expression [15]. Cellular uptake of NPs is primarily size
dependent. NPs smaller that 100 nm can cross the cellular membrane through en-
docytosis, a mechanism in which the nanomaterial is engulfed in vesicles [16]. The
group of Xia and others have shown that this process is highly dependent on the
molecules present on the NP surface. They show how gold NPs coated with a shell
of alternating hydrophobic and hydrophilic ligands behave differently crossing the
cell membrane compared to randomly ordered coated NPs [17]. From the research
work of Dawson et al., it is known that NP uptake into cells is dependent on the
presence of proteins adsorbed on the NP surface [16]. Proteins get adsorbed when
the NPs are inserted in an environment, like in the blood stream, or get adsorbed
during the synthesis and handling of the NPs, even working in the most clean
conditions [18, 19].
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From all these examples, the importance of surface chemistry when dealing
with biological materials is apparent.
1.1.2 Silica nanoparticle synthesis methods
Silica particles are prepared in a mixture of water, alcohol, and ammonia by
hydrolysis and condensation of alkoxysilanes. Alcohol is normally used as a homog-
enizing agent since alkoxysilanes and water are immiscible. The catalyst for the
hydrolysis and condensation can be a base or a acid. The hydrolysis takes places
by a nucleophilic mechanism. In a basic environment, water dissociates to produce
nucleophilic hydroxyl anions (OH−) in a rapid reaction, and then the hydroxyl
group attacks the silicon atom. A decrease in the electron density of the silicon
atom happens when the hydroxyl anion replaces an alkoxide group (OR), accel-
erating therefore the hydrolysis rate of other alkoxide groups. Once an alkoxide
group is hydrolyzed, the others will be hydrolyzed rapidly, followed by the con-
densation of Si(OH)4, resulting in the creation of monodisperse silica spheres [20].
The chemical reactions describing the hydrolysis and condensation of alkoxysilanes
can be briefly written as follows [21]:
Si(OR)4 + 4H2O = Si(OH)4 + 4ROH (1.1)
nSi(OH)4 = nSiO2 + 2nH2O (1.2)
The main alkoxysilane used in NP synthesis is tetraethyl orthosilicate (TEOS),
with the formula Si(OC2H5)4. This molecule consists of four ethyl groups attached
to SiO4
4− ion, which is called orthosilicate.
Figure 1.2: Chemical structure of tetraethyl ortosilicate (TEOS).
Spherical silica NPs are generally made by one of two chemical approaches,
reverse microemulsion or Sto¨ber sol-gel synthesis. Sto¨ber and co-workers in the
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late 1960s, developed a protocol based on the sol-gel chemistry of silicon alkox-
ides [22]. Sto¨ber’s method involves the hydrolysis and condensation of TEOS in
ethanol solution in the presence of water with ammonia as a catalyst to create
monodisperse, spherical, electrostatically-stabilized particles.
In the reverse microemulsion techniques, the hydrolysis and condensation of
TEOS happen inside tiny droplets of water enclosed in surfactants shells [23].
A microemulsion is a thermodynamically stable distribution in a continuous oil
medium of water droplets with size range of tens to hundreds of nanometers. The
surfactant molecules create reverse micelles around the water droplets with the
non-polar tails towards the oil phase, thus resulting in a confined environment or
nano-reactor in which the NP synthesis take place [24]. The micelles collide with
each other by Brownian motion and occasionally fuse together. When two droplets
containing different reactants collide and undergo fusion, the chemical reactions
takes place. The kinetics and dynamics of the microemulsion are regulated by the
dynamic character of the micelles [25]. A NP is formed inside the droplet when the
atoms of the insoluble reaction product being free in the micelle come together to
produce a thermodynamically stable cluster, in a process called nucleation. The
cluster goes on growing if the critical size is exceeded, otherwise spontaneous de-
aggregation can occur [26].
Figure 1.3: Schema of microemulsion synthesis of a dye doped silica nanoparticle.
Ref: adapted from [27]
The confined nanoreactor environment within the surfactant shell yields highly
monodisperse NPs with narrower size distributions than those obtained in the
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Sto¨ber synthesis. Moreover microemulsion-based synthesis aids the incorporation
of non-polar fluorophores, which are often difficult to integrate into the hydrophilic
silica matrix [28]. However, as the dye molecules are not covalently attached to
the silica matrix, over time the fluorophores can leach out of the NPs, conse-
quently decreasing NPs brightness, increasing background signal and releasing the
dye molecules in the environment. To prevent dye leaching, a step can be added
before the microemulsion synthesis in which the dye molecules are covalently con-
jugated with a silane coupling agent [29]. Another aspect of the microemulsion
method is that these syntheses often have low yields and that the use of surfactants
necessitates several washing cycling before the NPs can be used in any biological
applications. If some surfactant molecules are left on the NP surface, lysis or
disruption of cell membranes can occur [30].
1.1.3 Short overview of surface modification of silica
Surface modification of silica NPs can be done by coupling organosilanes or
organic molecules with the functional groups present on the NP silica surface.
On the NP surface there are two types of functional groups, siloxane (Si-O-Si)
and silanol (Si-OH). The reaction with the silanol group constitutes the princi-
pal modification pathway [31]. When the surface -OH groups are treated with
organofunctionalized silanes a Si-O-Si bond is created. Organosilanes in common
use are trialkoxysilanes, which react with the silanol groups releasing the corre-
sponding alcohol. Different trialkoxysilanes can be employed in the silica surface
modification. The methoxy- and ethoxy-silanes are the most effective due to their
greater reactivity. The reaction of the organosilane can happen via one, two or all
three alkoxy groups (see figure 1.4). As a consequence there can be some degree
of polymerization of the organosilane on the NP surface [31].
An example of surface modification is the addition of amino-groups on the NP
surface, also called amination. In this case the used silane coupling agent is amino-
propyltriethoxysilane (APTES), in which the R chain of figure 1.4 corresponds to
NH2-CH2-CH2-CH2, thus creating pendant amino groups on the silica surface.
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Figure 1.4: Modification of silica using triethoxysilane [31].
1.2 Importance of blood platelets
Platelets are small pseudocells in the blood that help control bleeding. They
plug small holes in blood vessels and assist in the clotting process. Platelets are
shaped like a disk with a diameter of about 2-3 µm. They cannot be considered
as true cells since they do not have a nucleus. The average lifespan of a platelet is
in average 10 days [32].
Platelets play a pivotal role in haemostasis because when an injury occurs they
are activated and mobilized quickly to create a haemostatic plug [33]. When the
subendothelial matrix is exposed upon vascular injury normal haemostasis takes
place [34] (see figure 1.5).
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Figure 1.5: Normal haemostasis after vascular injury. Ref: [34].
Platelets are critically involved in atherothrombosis (the hardening and nar-
rowing of the body’s arteries) and thromboembolism (formation of a clot that
breaks loose and is carried by the blood stream to plug another vessel) [35, 36].
The rupture of an atherosclerotic plaque or thrombosis can cause acute ischaemic
events like stroke (i.e. when the heart tissue is starved of nutrients like oxygen)
[37]. In these events platelet adhesion happens quickly, followed by activation
and aggregation [38]. The result is a thrombus that can obturate the vessel or
that can be carried away with the blood stream to create an embolus in a distal
artery. Thrombus formation can be induced by the rupture of an atherosclerotic
plaque and the consequent exposure of the matrix underlying in the vessel wall, as
shown in figure 1.6, or by pathological turbulent shear stress [36, 34]. It has been
Figure 1.6: Thrombus formation in response to atherosclerotic plaque rupture.
Platelets are activated upon exposure of the underlying lipid core, in particular
von Willebrand factor (vWF) and collagen. Ref:[34].
suggested that platelet reactivity increases in the event of an ischaemic stroke, as
underlined by the increase of products derived from platelet activation processes
[39]. Thus, studying the activation state of the platelets can be a tool for predict-
ing atherothrombotic events [40].
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Because of the crucial role of platelets in atherothrombosis, the study of them
is vital for the early diagnosis of life-threatening diseases.
1.2.1 Platelet activation and role of receptors
Platelets circulating in the blood are activated when collagen fibrils and throm-
bin are exposed. Collagen, that is present in the outermost layer of a blood vessel,
is exposed after damage in the vein wall, and thrombin is locally produced at sites
of vascular injury. Platelets adhere to the vessel walls employing von Willebrand
factor (vWF) as a cofactor. They change their shape spreading out on the wall
surface, and form a monolayer on the damaged area [41]. More platelets are then
recruited through the continued action of thrombin and the secretion of soluble
molecules such as ADP and P-selectin. As more platelets become activated, they
stick to each other (cohesion) increasing the height of the haemostatic plug. A
schematic of platelet adhesion and cohesion on a vein wall is shown in figure 1.7.
Plug stability is sustained by the continued signaling within platelets. Fibrino-
gen, von Willebrand factor and other ligands bind to activated integrins which are
present on the platelet surface, ensuring therefore stable contacts between platelets.
Platelet-platelet contacts allow the binding of ligands on the surface with receptors
on the surface of nearby platelets. Molecules secreted by activated platelets are
accumulated in the gaps between platelets [42].
Several functional receptors are present on the surface of a platelet. These
receptors are involved in the adhesion process between platelet and platelet and
between platelet and the extracellular matrix. These receptors are also involved in
the activation process and in the recruiting of additional platelets. When platelet
receptors bind to ligands or to counter-receptors they transmit intracellular sig-
nals, modulating changes in the receptors profile, and activating signalling path-
ways [34]. The most important platelet receptors are glycoprotein (GP) Ib-IX-V,
GPVI, and the integrin αIIbβ3. After the engagement of primary platelet adhe-
sive receptors such as GPIb-IX-V or GPVI, fast activation of platelet integrins
like of αIIbβ3 takes place. When the platelet is activated, the integrin αIIbβ3
goes through a conformational change like in a “switch-blade” mechanism (Fig.
1.8). Once αIIbβ3 is in the extended conformation, it binds to fibrinogen or to
vWF. The binding of αIIbβ3 to the von Willebrand factor after Ca2+-dependent
activation is critically involved in thrombus formation at high shear stress [34].
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Figure 1.7: Platelet adhesion and cohesion after exposure of the vessel underlying
matrix. Ref: [42].
An activated platelet can therefore be distinguished from a resting platelet by
looking at the conformation status of its integrins αIIbβ3. A peculiarity of the
activation process is also the surface exposition of insoluble molecules, like of P-
selectin. P-selectin is a protein found in the storage granule membrane of unstim-
ulated platelets which becomes translocated to the surface of activated platelets
[43]. This work involves labelling of activated platelets only or using specific an-
tibodies which can bind just to the activated form of αIIbβ3, or using antibody
towards the secreted P-selectin.
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Figure 1.8: Activation through conformational change of the integrin αIIbβ3 that
binds vWF or fibrinogen and mediates platelet aggregation. Ref: [34].
1.3 Basics of Fluorescence Spectroscopy
The emission of light that occurs from electronically excited states is called
luminescence [44]. When light arises from the relaxation of a singlet excited state,
it is called fluorescence, and when it arises from a triplet excited state it is called
phosphorescence. From a spectroscopic point of view these processes are easily
separable because of their different characteristic life-times.
The life-time, τ , is the average time that a molecule spends in the excited state be-
fore de-exciting to the ground state and τ is the temporal parameter that describes
the luminescence process kinetics, given by
N(t) = N0 exp
− t
τ (1.3)
where N(t) is the number of photons observed at a time t after an excitation pulse
has illuminated an ensemble of fluorophores and N0 is the number of photons de-
tected at time t = 0.
The absorption and emission of light can be described in terms of the Jablonsky
diagram (fig. 1.9). The ground state, the first and second excited singlet and the
first and second excited triplet states are indicated respectively as S0, S1, S2, and
T1, T2. For each state there exist several vibrational states. At room temperature
the energy gap between S0 and S1 is too large for thermal population of S1, so a
light source is necessary to induce fluorescence. After the absorption of light, which
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Figure 1.9: Jablonski diagram.
occurs in about 10−16 s, several processes take place. A fluorophore can be excited
to a higher vibrational state of either S1 or S2, after which the molecule relaxes
rapidly to the lower vibrational level of S1. This process is called internal conver-
sion and takes place in ≈ 10−12 s. Alternatively the fluorophore can undergo a spin
conversion to T1, in a process called intersystem crossing. The transition T1 → S0
is forbidden as the electron in T1 has the same spin orientation as the electron
in S0. This forbidden transition rule reflects on the rate of the phosphorescence
process. Phosphorescence life-times for these transitions span from milliseconds to
seconds. However the decay from S1 to an excited vibrational state of S0, which
gives fluorescence emission, occurs on the nanosecond time scale and is followed by
a picosecond transition to the ground vibrational state of S0. This is an allowed
transition because the electron in the excited orbital is paired to a second electron
of opposite spin in the ground state [44].
The emission spectrum which is a plot of fluorescence intensity versus wave-
length at fixed λexc, is a characteristic of a particular fluorophore, because it de-
pends upon the chemical structure of the fluorophore and shows the structure due
to the individual vibrational energy levels of the ground and the excited state (see
fig. 1.10). The absorption or excitation spectrum is a plot of the wavelength de-
pendence of the absorbed light. By plotting fluorescence data as excitation and
emission spectra it is easy to see two other features: the Stokes’s shift and Kasha’s
rule.
Referring to the Jablonsky diagram (figure 1.9) it is clear that between absorption
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Figure 1.10: Sketch of normalized excitation and emission spectra for a fluorophore.
The separation between the two is due to Stokes’s shift. Kasha’s rule is shown by
the arrows.
and fluorescence emission there is loss of energy due to the relaxation to the lower
vibrational level of S1 by internal conversion. Moreover the transition S1 → S0
involves higher vibrational levels of S0 that rapidly raise the equilibrium resulting
in a further loss of energy. As a result, the emission of light takes place at lower
energy (higher wavelengths) with respect to excitation. This phenomenon is called
the Stokes’s shift, since it was first observed by Sir George Gabriel Stokes in 1852.
Kasha’s rule states that the emission spectra are independent of excitation wave-
length. This is because after absorption the fluorophores rapidly relax to the lowest
vibrational state of S1 from which any transition to S0 begins. The relaxation is
probably the result of overlapping among numerous states of nearly the same en-
ergy.
A fundamental parameter that characterizes fluorescence emission is the quan-
tum yield, φF . It is the emitted/absorbed photons ratio and is defined as [44]:
φF =
Γ
Γ + knr
(1.4)
where Γ is the emission rate of the fluorophore and knr the rate of the non-
radiative decay processes to S0. φF is always < 1 due to the Stokes losses of energy
and becomes close to unity when knr << Γ. Because τf is defined as the time a
molecule spends in the excited state before relaxing to S0, it is determined by the
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rate of all the processes that depopulate S1:
τf =
1
Γ + knr
(1.5)
Due to the fact that fluorescence is a random process, only a fraction of the
molecules relax exactly at t = τf , therefore τf is an average value of the time spent
in S1. For a single exponential decay, 63% of the molecules relax at t < τf and
37% at t > τf .
1.4 Fluorescence Imaging
Imaging of a sample can be achieved by collecting the fluorescence light emit-
ted upon light excitation. In the process of one photon absorption, the rate of
absorption is linear with respect to input intensity of light. A laser focused by an
objective is assumed to have a Gaussian shape both in the object plane and in the
optical path direction [45], with therefore a non-zero intensity in the out-of-focus
planes. The consequence is that the excitation volume is not confined in the focal
plane, and also the planes above and below the focus get excited in an hourglass
shape as shown in figure 1.11.
Figure 1.11: Excited volumes by one-photon laser source λ = 380 nm in fluorescein
solution.
Ref: adapted from http://belfield.cos.ucf.edu/one%20vs%20two-photon%20excitation.html
One-photon excitation does not allow optical sectioning. Optical sectioning is
obtained by spatial filtering the emission in front of the detector. Nowadays one
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photon fluorescence imaging is mainly performed under confocal detection (see
section 2.1.1).
One drawback of using a lamp source when imaging a point into the specimen
is that there are fewer emitted photons to collect at any given instant. Thus, to
avoid building a noisy image, each point must be illuminated for a long time to
collect enough light to make an accurate measurement. In turn, this increases the
length of time needed to create a point-by-point image. The solution is to use a
light source of very high intensity. The modern choice is a laser light source, which
has the additional benefit of being available in a wide range of wavelengths [46].
Unfortunately, fluorescence emission has not an infinite duration as molecules
can undergo photobleaching. The phenomenon of photobleaching occurs when a
fluorophore permanently loses the ability to fluoresce due to photon-induced chem-
ical damage and covalent modification. Upon transition from an excited singlet
state to the excited triplet state, fluorophores may interact with another molecule
or with light to produce irreversible covalent modifications. The triplet state is rel-
atively long-lived with respect to the singlet state, thus allowing excited molecules
more time to undergo chemical reactions with components in the environment.
The average number of excitation and emission cycles that occur for a particular
fluorophore before photobleaching is dependent upon the molecular structure and
the local environment.
The excitation power released per plane is independent of the focusing plane po-
sition along the optical axis. Thus, the main drawback of techniques like confocal
microscopy is the photobleaching of molecules in out of focus planes which leads
to degradation of the image.
1.5 Main objectives of the work
To design and implement a platform to investigate the activation state of
platelets.
Key elements of the work are:
• Nanoparticle synthesis and characterization
• Nanoparticle-platelet interactions
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• Platelet immobilization on surfaces
• Morphology and fluorescence signal of platelets
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Chapter 2
Materials, methods and
instrumentation
2.1 Instruments
2.1.1 Laser scanning confocal microscope
One photon fluorescence imaging, whose principles has been described in section
1.4, is nowadays extensively performed under confocal detection. The confocal
microscope incorporates the ideas of point-by-point raster scanning of the specimen
and rejection of out-of-focus light. The rejection of out of focus light is achieved
by placing a screen with a pinhole in front of the detector. The focal point of
the objective lens forms an image onto the pinhole screen. The specimen plane
and the pinhole screen are conjugate planes (and hence the name “confocal”). By
using a laser scanning confocal microscope two- and three-dimensions pictures of
the specimen can be obtained, as well as a temporal series of 2D images. The
description of how an image is created is as follows: a laser beam passes a light
source aperture and is then focused by an objective lens into a small focal volume
within a fluorescent specimen. A mixture of emitted fluorescent light as well as
reflected laser light from the illuminated spot is then recollected by the objective
lens. A beam splitter separates the light mixture by allowing only the laser light to
pass through and reflecting the fluorescent light into the detection apparatus (fig.
2.1). After passing the pinhole the fluorescent light is detected by a photodetector,
for example a photomultiplier tube (PMT) or avalanche photodiode, transforming
the light signal into an electrical one which is recorded by a computer. The detector
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Figure 2.1: Basic setup of a confocal microscope. Light from the laser (blue) is
scanned across the specimen by the scanning mirrors. Excitation light and fluo-
rescence emission (green) are separated by a dichroic splitter. Optical sectioning
occurs as the fluorescence light passes through a pinhole on its way to the detector.
aperture obstructs the light that is not coming from the focal point, as shown in
figure 2.2. The out-of-focus points are thus suppressed. Most of the returning light
is blocked by the pinhole. This results in sharper images compared to conventional
fluorescence microscopy techniques and permits one to obtain images of various z
axis planes (z-stacks) of the sample.
Figure 2.2: Schematic of how a pinhole aperture placed in front of the detector
rejects the out of focus light. The light coming from the in-focus plane (solid line)
passes through the pinhole, while the light coming from the planes under it (fine
dotted line) and over it (dashed line) are blocked.
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The detected light originating from an illuminated volume element within the
specimen represents one pixel in the resulting image. As the laser scans over the
plane of interest a whole image is obtained pixel by pixel and line by line, while
the brightness of the resulting image pixel corresponds to the relative intensity
of detected fluorescence light. The beam is scanned across the sample in the
horizontal plane using one or more (servo-controlled) oscillating mirrors. The scan
speed can be varied. Slower scans provide a better signal to noise ratio resulting in
better contrast and higher resolution. Information can be collected from different
focal planes by raising or lowering the microscope stage.
The ability of a confocal microscope to create sharp optical sections makes it
possible to build 3D profiles of the specimen [47].
2.1.2 Dynamic light scattering
Dynamic light scattering (DLS) measures the time-dependent fluctuations in
the intensity signal of the scattered light. From this measurement it can be deter-
mined the translational diffusion coefficient, which is related to the hydrodynamic
diameter of the particles in solution. The rate of intensity fluctuation is dependent
upon particle size. The intensity fluctuations for smaller particles have a higher
frequency than for larger particles (see figure 2.3). The scattering intensity sig-
Figure 2.3: Scattering intensity fluctuations for a sample of a) small particles, and
b) larger particles.
nal is passed into a digital correlator which multiplies and integrates short time
scale fluctuations in the signal measured over a delay time τ , as shown in figure
2.4. The output is the correlation function for the sample. The correlation func-
tion describes how much a signal is similar to itself over a sample time τ , chosen
appropriately according to the time characteristics of the signal. It is calculated
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Figure 2.4: Scattering intensity is recorded every t and t+τ , and is mathematically
processed by the correlator which gives as output the correlation function.
as
G (τ) =
∫ 0
∞
I (t) I (t+ τ) dt (2.1)
and, for samples containing monodisperse particles, it is a single exponential decay
G (τ) = A[1 +B · exp(−2Γτ)] (2.2)
where A is the baseline and B the intercept of the correlation function, Γ = Dq2
where D is the translational diffusion coefficient and q = (4pin/λ) · sin (ϑ/2), with
n refractive index of solution, λ is the wavelength of the laser, and ϑ the scattering
angle.
For polydisperse particles the correlation function is
G (τ) = A[1 +B · g1 (τ)2] (2.3)
where g1 (τ) is the sum of all exponential decays contained in the correlation func-
tion.
The diffusion coefficients are extracted by fitting the correlation function with
a suitable algorithm, and the resulting diffusion coefficient distribution can be
converted into a particle size distribution using the Stokes-Einstein equation, as
shown in figure 2.5. The Stokes-Einstein equation (2.4) relates the particle hydro-
diameter d to the diffusion coefficient D
d =
kbT
3piηD
(2.4)
where kB is the Boltzman constant, T the temperature, η the sample viscosity.
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Figure 2.5: Intensity of scattering versus time pass through a correlator, which
plots a correlation function that is fitted to obtain the size distribution of the
sample.
To obtain the size distribution from the correlation function, the function is
plotted on a semi-log plot (note: if the distribution is polydisperse, the semi-log
plot is curved), and then it is fitted with a third order polynomial
Ln[G] = a+ bτ + cτ 2 (2.5)
from which the value b gives the z-average diffusion coefficient, which then gives
the mean diameter of the particles. The ratio 2c/b2 is the polydispersity index,
PDI, which describes the width of the distribution of the sizes. PDI can vary from
0 to 1 values, with 0 being a 100% monodisperse sample. Generally values of PDI
lower than 0.1 are almost monodisperse samples and samples with PDI lower than
0.3 are accepted to be good monodisperse samples. Samples with PDI higher than
0.7 indicate a very polydisperse sample, and care should be taken in interpreting
results as the sample may not be suitable for the technique, e.g. a sedimenting
high size tail may be present.
2.1.3 Freeze-dryer
Freeze drying is used to dry nanoparticles after synthesis to obtain the mass of
the sample. A typical freeze-dryer consists of one or more freeze-drying chambers
attached to heating units, a freezing coil connected to a refrigerator compressor,
and a vacuum pump (fig. 2.6). The material is placed in the chamber when it is
still at room temperature. When the chamber is sealed and the process begins, the
instrument activates the compressors which lower the temperature. The material is
frozen solid, separating the water from the molecules surrounding it. The vacuum
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Figure 2.6: Schematic of a freeze dryer. There is usually a chamber with usually
shelves, or a manifold with the possibility to attach several flasks controlled by
separate valves.
pump is then run to lower the atmospheric pressure below 0.06 ATM by forcing air
out of the chamber. The change of phase of water happens when the heating units
apply a small amount of heat to the chamber. Since the pressure is so low, the ice
turns directly into water vapor in a process known as sublimation. This continues
for many hours while the material gradually dries out. Once the material is dried
sufficiently, the chamber is brought back to ambient pressure, and the material
removed.
2.1.4 Aggregometer
An aggregometer is an instrument designed to measure platelet aggregation
in platelet rich plasma (PRP). An aggregometer is a specialized photometer for
plasma which relates the relative transmitted light through a plasma sample to
its aggregation status. A measurement is generally performed placing the PRP in
an incubation well which heats the sample to 37◦ C for 10 minutes before testing.
PRP is then transferred to the reaction well, where the samples are stirred and
data are recorded. The stirring device turns the stir bar in the cuvette from 800
to 1200 rpm, keeping the platelets in suspension. The transmitted light is sent
to a photomultiplier and a recorder. As the PRP is stirred, the recorder first
stabilizes to form the baseline, which is close to 0% transmission. After a few
seconds, an aggregating agonist is pipetted forcibly into the specimen to start
the reaction. In a normal specimen, after the agonist is added, the platelets’
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shape changes from discoid to spherical. The intensity of the transmitted light
increases slightly in proportion to the degree of shape change. The transmittance is
monitored continuosly and recorded into a time-plot. As platelet aggregates form,
more light passes through the PRP, and the recorder begin to move towards 100%
light transmission. Aggregation is complete in 6 to 10 minutes. Abnormalities are
reflected in diminished or absent shape change and diminished aggregation [48].
2.1.5 Flow cytometry
Flow cytometry uses the principles of light scattering, light excitation, and
emission of fluorochrome molecules to generate specific multi-parameter data from
particles and cells in the size range of 0.5 µm to 40 µm diameter. Cells, suspended
in a medium like PBS or HEPES buffer, are placed in a cuvette in the instrument.
The instrument takes an amount of liquid, and passes the fluid in a sheath in
a hydro-dynamically focused stream. The flow is reduced in diameter, forcing
the cells into the center of the stream, and then the flow intercepts an optimally
focused laser light source. Cells pass the laser light one cell at a time. As the cells
or particles of interest intercept the light source they scatter/emit fluorescence,
which is sent to different detectors (generally photomultiplier tube (PMT)) by
using optical filters (see figure 2.7).
Figure 2.7: Schematic of a flow cytometry instrument.
27
Forward scattering (FS) is the amount of light that scatters in the forward
direction as laser light strikes the cell. From the analysis of the forward scattering,
obtained from a detector placed directly in the path of the laser, is obtained infor-
mation about the size of the cell, as shown in figure 2.8. A cell traveling through
Figure 2.8: A smaller cell scatters the light differently from a larger cell, therefore
the electric pulse recorded is weaker in amplitude compared to a larger one.
the laser beam scatters light at all angles. Side scatter is caused by granularity
and structural complexity inside the cell. The side scattering (SS) is collected by
a detector placed at 90◦ from the laser path.
Fluorescence light arising from fluorophores which are excited is separated by opti-
cal filters and recorded into different channels, normally labelled as FL1, FL2 and
FL3.
Histogram files can be in the form of one-parameter or two-parameter files. A
one-parameter histogram is a graph of cell count on the y-axis and the measure-
ment parameter on the x-axis (like FL1). A two-parameter histogram is a graph
representing two measurement parameters (like FS and SS), on the x- and y-axes,
and cell count height on a density gradient. Particle counts are shown by dot
density or by contour plot.
2.1.6 Atomic Force Microscopy
Atomic force microscopy (AFM) is a high-resolution type of scanning probe
microscopy. There are some significant advantages of AFM as an imaging tool in
biology and physics when compared with other techniques. AFM achieves molecu-
lar resolution and can also be performed in fluids permitting samples to be imaged
in near native conditions. The fluid may be exchanged or modified during imaging
and therefore there is the potential for observing biological processes [49].
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To acquire an image the microscope raster-scans a mechanical probe/tip over
the sample while measuring the local environment in question. Unlike tradi-
tional optical microscopes, scanned-probe systems do not use optical radiations
and lenses. Resolution is therefore limited only by the size of the probe, rather
than diffraction effects like in optical microscopes [50]. AFM operates by measur-
ing attractive or repulsive forces between a tip and the sample. When the tip is
driven close to a sample surface, a deflection of the cantilever occurs because of
forces between the tip and the sample as described by the Hooke’s law
∆z =
∆F
kc
(2.6)
where the deflection ∆z is given by the acting force ∆F and the spring constant
of the tip kc.
The different imaging modes of AFM make it an instrument suitable for dif-
ferent applications. Imaging modes can be static(also called contact modes) or
dynamic (or non-contact modes) where the cantilever is oscillated.
In contact mode the tip is raster-scanned across the 3D surface. The cantilever
is bent as it moves over the surface profile and its deflection is measured by the de-
tection apparatus. By looking at the cantilever deflection the local sample height
can be measured. The deflection is measured with picometer resolution by an opti-
cal lever, which operates by reflecting a laser beam off the cantilever. The reflected
laser beam hits a detector composed of two or more side-by-side photodiodes, as
shown in figure 2.9. The difference between the signals of the photodiodes indi-
cates the position of the laser spot on the detector and thus the deflection of the
cantilever. When the tip is scanned over the sample surface then the deflection of
the cantilever can be recorded as an image which represents the three dimensional
shape of the sample surface (deflection image).
In constant force mode, the deflection is maintained constant by continuously
adjusting the tip. To avoid collisions between the tip and the surface and a possi-
ble consequent damage of the sample, the tip is not driven at a constant z-height.
The tip-to-sample distance is regulated by a feedback mechanism by keeping fixed
the force between the tip and the surface. The faster the feedback loop can react
to the cantilever deflections, the faster the AFM can acquire images. The ability
to track the surface in this manner is limited by the feedback circuit only.
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Figure 2.9: Concept of AFM and the optical lever. The laser spot is focussed
on the back of the cantilever and the angle of the reflected laser is detected by a
photodiode.
Soft samples like biological samples provide a more difficult surface to image
because the forces exerted by the tip during imaging can cause deformation of the
sample. Operating the AFM in tapping mode improves lateral resolution on soft
samples. Instead of maintaining a constant tip-sample distance, the cantilever is
oscillated in a direction normal to the sample. The contact with the surface is
therefore only intermittent, reducing the lateral forces applied on the sample as
the tip is raster-scanned. The lateral forces such as drag, which could be cause of
damage, are therefore virtually eliminated [50].
In tapping mode the cantilever is oscillated with a frequency close to the tip’s
resonance frequency or to one of its harmonics. The amplitude of the oscillation
is typically a few nanometers (<10 nm). The oscillation amplitude, phase and
resonance frequency are modified by tip-sample interaction forces. During its os-
cillation the tip reaches the region where repulsive forces arise. The long range
forces such as van der Waals, which are dominant from 1 nm to 10 nm above
the surface, decrease the resonance frequency of the cantilever. The decrease in
the resonance frequency is combined with the feedback loop system to maintain a
constant oscillation amplitude or frequency by adjusting the average tip-to-sample
distance. Measuring the tip-to-sample distance at each (x,y) data point allows the
scanning software to construct a topographic image of the sample surface [51].
For ideal samples and conditions the AFM is capable of better than 1 nm lateral
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resolution and of 0.01 nm resolution in height measurement [49].
2.2 Biological buffers and fixatives
2.2.1 Buffers
Why use a buffer
In the preparation of biological samples, buffers are used to suspend or wash
the cells. Biological samples have a certain pH and a certain intracellular ion
concentration. Many chemical reactions occurring in a cell are affected by the
acidity of the surrounding medium. Changing the pH of the reaction solution can
inhibit a particular reaction or change its reaction rate. Moreover biochemical
reactions are especially sensitive to pH since many molecules contain atoms that
may be charged or neutral depending on pH. A change in the charge of these
atoms has significant consequences on the biological activity of the molecule. It is
therefore important to control the pH by using buffer solutions.
Buffers always consist of an acid mixed with its corresponding base. The pH
of this kind of solution can be written with the Henderson-Hasselbalch equation
pH = pKa + log
[A−]
[HA]
(2.7)
where [A−] is the concentration of the conjugate base, [AH] is the concentration
of the acid and pKa is the acid dissociation constant
Ka =
[H+][A−]
[HA]
. (2.8)
When the concentration of base equals the concentration of acid, the ratio of
equation 2.7 is one and the pH equals the pKa. A change in the pH of -1/+1
happens when the ratio decrease/increase of as much as a factor of ten. Therefore
solutions having pH value close to their pKa value have the property of maintaining
the pH relatively constant when neutralizing added acids and bases (in the so called
“buffering region”).
The use of the correct buffer assures that the cells are kept alive and unaltered
in their main functionalities.
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PBS preparation
Phosphate buffered saline (PBS) is a water-based salt solution containing sodium
chloride, sodium phosphate, potassium chloride and potassium phosphate. The
buffer helps to maintain a constant pH. It is a buffer largely used with biological
samples since it is isotonic (ion concentration of the solution is the same as in the
human body), has physiological osmolarity and it is non-toxic to cells.
In this project PBS is prepared by diluting 137mM NaCl, 2.7mM KCl, 1mM
Na2HPO4 and 1.76mM KH2PO4 in purified and deionized water (Milli-Q). The
pH of the buffer is adjusted to pH 7.4 with the addition of 1M NaOH. PBS was
stored at room temperature.
HEPES preparation
In this work, HEPES buffer has been used for washing the platelets before
fixation occurs, or as a diluting solution for plasma. HEPES (4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid) is a buffering agent containing both positive and
negative ionizable groups. HEPES buffer is widely used in cell culture, largely
because, compared to other buffers commonly used in cell culture, it is better at
preserving physiological pH when changes in carbon dioxide concentration occur.
It is prepared with salts and sugar: in a clean flask are added 137 mM NaCl, 2.7
mM KCl, 1 mM MgCl2, 5.6 mM glucose and 20 mM HEPES diluted in purified
and deionized water (Milli-Q). The solution is then brought to pH 7.4 with the
addition of 1M NaOH. The buffer so prepared has to be stored in a fridge and used
within a week, or it can be aliquoted and frozen and thawed when needed.
2.2.2 Fixatives
Fixation process
Fixation is a step in the preparation of biological samples performed to preserve
cells and tissue constituents in a state as similar as possible to the live-state and
to prepare them for the further preparative procedures. Fixation stops autoly-
sis and bacterial decomposition and stabilizes the cellular and tissue constituents.
Aldehydes are crosslinking fixatives that act by creating covalent chemical bonds
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between proteins in tissue. These extra bonds anchor proteins which otherwise
would be soluble to the cytoskeleton and increase the rigidity of the tissue.
PFA preparation
Paraformaldehyde (PFA) is one of the most common crosslinking fixatives.
Paraformaldehyde is the condensation reaction product of formaldehyde consisting
of connected formaldehyde molecules. The units of the paraformaldehyde polymer
are –CH2O–; at one extreme of the polymer chain there is an OH group and at the
other a hydrogen atom: H0–(CH2O)nH, where n can vary between 8-100. When
Figure 2.10: Paraformaldehyde chemical structure.
used on cells, the aldehyde group can bind to nitrogen and some other atoms
of proteins forming a methylene bridge. Formaldehyde acts as a fixative entirely
through its reactions with proteins. Other substances, like carbohydrates, lipids
and nucleic acids, remain trapped in a matrix of cross-linked proteins but are not
chemically changed unless fixation is protracted for several days [52].
In this work PFA solution 3.7% (w/v) is used to fix platelets for light microscopy
analysis. The protocol used to prepare the solution is the following: 1.85 grams of
PFA are mixed with 3.5 ml of Milli-Q water and 50 µl of NaOH 2N. To be able to
dissolve the powder, the flask is heated in a hot water bath. The obtained solution
is then diluted 1:10 in phosphate buffered saline and stored in the dark.
Glutaraldehyde preparation
An other crosslinking fixative used in cell preparation is glutaraldehyde. Glu-
taraldehyde is composed of small units separated by 3 methylene bridges. The
glutaraldehyde chemical formula is HCO-(CH2)3-CHO, from which can be seen
that each of the units have two aldehyde groups. This translates in an increased
potential for cross-linking than with paraformaldehyde because the cross linking
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reactions can occur through both the -CHO groups and over variable distances [52].
The free aldehyde groups are protruding from the side of each units of the polymer
chain and from both of the extremes. All these -CHO groups will combine with
any nitrogens present in the close environment, therefore there is a big potential
for cross-linking with proteins (see figure 2.11). Glutaraldheyde solution does not
Figure 2.11: Reaction of poly(glutaraldehyde) with amino groups of proteins.
emit fluorescence, but after glutaraldehyde reacts with the sample, enhancement
of cells’ autofluorescence occurs [53].
In this project, for platelet fixation, glutaraldheyde is used in a dilution of 1%
(w/v) in Milli-Q water.
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2.3 Blood handling protocol
Blood is obtained from healthy volunteers. Fresh blood is drawn by a syringe
containing a volume of sodium citrate (3.8% (w/v) in water), in a volume ratio
1:10 of blood, to prevent blood coagulation.
Platelet rich plasma (PRP) is obtained by centrifuging the blood at 170 RCF for
10 minutes. Upon centrifugation, the clear supernatant, that is the platelet rich
plasma, is removed by pipetting. The remaining denser sample is centrifuged again
at 720 RCF for 10 minutes to obtain the platelet poor plasma (PPP), which is the
yellowish supernatant over the thick dark red solution.
Samples to be disposed of are neutralized with a disinfectant against viruses
and bacteria, Virkon R©.
Blood samples are handled only in a specific biohazard fume hood. The bio-
hazard designated area has been independently assessed by a HEA inspector. All
protocols and handling for the safe practice of using live biological samples from
human origin have been liaised with the DCU Biological Safety Committee, with
the advice of Dr. Robert O’Connor (The University Biological Safety Advisor).
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Chapter 3
Nanoparticle synthesis and
functionalization
3.1 Introduction
This chapter describes the experiments involving:
• nanoparticle synthesis and characterization
• nanoparticle surface modification
• antibody conjugation to nanoparticles.
3.2 Nanoparticle synthesis and charactherization
3.2.1 Introduction
The goal is to synthesize dye doped silica NPs and to conjugate them to an
antibody towards a platelet receptor, in order to use the NPs as labels for activated
platelets only.
We chose silica as an encapsulation material for the reasons already explained in
section 1.1.1. The criteria for selecting the dye is that it must absorb in the red or
near infra-red region of the spectrum. Haemoglobin in the blood absorbs all over
the visible spectrum up to 600 nm, as shown in figure 3.1. Therefore, when using
NPs in bioassays, a dye absorbing in the near infra-red region assures a minimal
absorption from haemoglobin.
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Figure 3.1: Absorption of oxy-haemoglobin (Hb02) and deoxy-haemoglobin (Hb).
Ref: http://www.indiana.edu/ sexlab/ei-vp-uvaprobe.html
The dye chosen was 4,5-Benzo-5’-(iodoacetaminomethyl)-1’,3,3,3’,3’-pentamethyl-
1-(4-sulfobutyl)indodicarbocyanine, commonly referred as NIR664-iodoacetamide,
with formula C37H42IN3O4S. This dye has already been successfully encapsulated
into silica NPs “in house”, showing a good stability and a good fluorescence yield.
It is soluble in methanol, with absorption maximum at λ =664 nm, and fluores-
cence emission maximum at λ =689 nm, ensuring minimal absorption from the
blood components.
Figure 3.2: Chemical structure of NIR664-iodoacetamide.
The required NP diameter has to be in the range of 60-150 nm. As explained
in section 1.1.1, NPs with diameters of the order of tens of nanometers tend to be
taken up in the cell; instead our aim is to use the NPs as an external probe for the
platelets, targeting chosen receptors on the platelet surface. On the one hand a
larger size not only avoids the NPs being uptaken non-specifically, but also allows
for the possibility of more dye molecules being embedded in the silica matrix, hav-
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ing therefore a brighter label and lowering the limit of detection (LOD). On the
other hand, a NP which is too large can also cause problems. It can occupy too
much space on the platelet surface, leading to a small number of NPs labelling the
platelet. It can also have too many antibodies attached on its surface, promoting
repulsion or clustering between the NPs themselves.
3.2.2 Synthesis by the microemulsion process
To synthesize NPs doped with NIR664, we followed a protocol established in-
house [29].
The first step involves the conjugation of the dye to a silane, in order to increase
the affinity of the dye with the TEOS. Since NIR664 has a iodoacetamide group
(see fig. 3.2), it is suitable for the derivatization of thiols. Therefore it can be
conjugated to any molecule having a pendant SH group, like, for our purposes, to
(3-Mercaptopropyl)triethoxysilane (MPTES) (figure 3.3).
For dye conjugation the dye is first dissolved in hexanol for a final concentration
Figure 3.3: Chemical structure of MPTES, containing the end SH group.
of ≈ 10−3 molar. Addition of MPTES, in a molar ratio 2:1 with the dye, takes
place in a glove box. The dye solution is then left inside the glove box, constantly
under stirring, for about 3-4 hours protected from the light.
A key point in the dye conjugation process is the importance of working in a sealed
protection atmosphere. The mercaptosilane is largely sensitive to humidity present
in the air and it can hydrolyze before being conjugated to the NIR664 dye. In early
experiments performed outside of the glove box, the products obtained after the
microemulsion synthesis were a whitish sediment, which translates to an unsatis-
factory inclusion of the dye into the silica matrix. The most significant failures in
dye inclusion were obtained under high humidity conditions, supporting the thesis
of incomplete dye conjugation because of hydrolysis of the mercaptosilane.
Another important parameter is the incubation time. In experiments with in-
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cubation time longer than 5 hours, the product obtained was a solid compact
sediment impossible to re-disperse. Large clusters are still present in solution
even after a long time of ultrasonication and they are not dispersable even after
mechanical crushing. For an optimal incubation time of the dye with the mercap-
tosilane one molecule of NIR664-iodoacetamide is conjugated with one molecule of
MPTES. Longer incubation times can lead to the formation of clusters of 3 or more
molecules, affecting therefore the silica condensation process during NP synthesis.
It is also important that the reaction takes place in the dark, to prevent damage
to the dye from photobleaching.
The second step is the microemulsion synthesis. In a flask are added, in order,
3.8 g of Triton-X as a surfactant, 15 mL of cyclohexane as the main oil phase, 2 mL
of dye-conjugated solution plus 1.6 mL of hexanol, and 960 µl of deionized water.
The solution is then sonicated for a short while and left stirring for about 5 minutes
in order to have a uniform distribution of water nanocompartments. Afterwards
200 µl of TEOS are added. Molecules of TEOS and of dye conjugated to MPTES
migrate into the droplets and the reaction of hydrolysis of the alkoxysilanes slowly
takes place due to the presence of the reactant (water). After 30 minutes stirring,
80 µl of ammonium hydroxide solution (28% in water), which acts as a catalyst,
is added to speed up the hydrolysis and the condensation process of silica. The
solution is then left stirring for 24 hours at room temperature.
In the third step, the NP surface is modified by the addition of amino groups.
The protocol involves the introduction of the desired functional group(s) on the sur-
face of the primary dye-doped silica NPs by condensation of TEOS and organosi-
lane reagents containing the active functional groups. Amino groups are intro-
duced using (3-aminopropyl)-trimethoxysilane (APTMS), and methylphosphonate
groups are introduced by 3-trihydroxysilyl)propyl methylphosphonate (THPMP),
a water-dispersible silane reagent, as can be seen in figure 3.4.
For the surface modification, in the same flask where the synthesis is still taking
place, are added 100 µl of TEOS, 30 minutes later are introduced 80 µl of THPMP
and five minutes later 20 µl of APTMS are added, constantly under stirring.
As described by Bagwe and others [54], APTMS condenses together with
TEOS, creating amino groups on the NP surface, and THPMP, which introduces
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Figure 3.4: Chemical structure of A) APTMS, B) THPMP. APTMS is used to
add amino groups -NH2 on NP surface.
methylphosphonate groups on the NP surface, is used as a stabilizer against ag-
gregation. The stability of NPs in solution is primarily measured by the zeta
potential of the sample. The zeta potential of undoped and unmodified silica NPs
is in the range of -40 mV ∼ -30 mV, hence agglomeration of NPs is forbidden by
electrostatic repulsion. Since the pKa value of the amine groups is 9.0, when high
concentrations of amine groups are added to the surface at physiological pH, the
positively charged amino group can bond to negative surface silanol groups. The
overall charge on the surface is so reduced, with a zeta potential value close to zero,
thus reducing the electrostatic repulsion between the NPs and therefore increasing
NP agglomeration. As the amount of inert functional group methyl phosphonate
is added to the surface, due to its low pKa value of 2.0, the zeta potential value
of NPs become more highly negative. Most of the amino groups on the silica sur-
face interact with methylphosphonate groups preventing back-bonding and strong
electrostatic repulsion forces arise between NPs, as shown in figure 3.5.
The time interval between the addition of TEOS and the organosilane reagents is
important because, if kept too short, most of the active functional groups would
be buried inside the particles, as the condensation reaction of the organosilane is
faster than that of tetraethylorthosilicate.
The last step in NP synthesis is extraction and washing of NPs. To stop the
synthesis, an equal volume of acetone is added to the reaction flask. Acetone addi-
tion causes a flocculation process in which NPs accumulate and slowly precipitate.
Complete precipitation is achieved after centrifugation at 3200 RCF for 5 minutes.
The supernatant containing all the unreacted products and the dissolved reagents
are discarded. NPs are confined in the solid colored sediment. Several washes in
ethanol and then in water are performed in order to completely remove any ad-
sorbed molecules on the NP surface. NPs are dispersed in ethanol or water after ≈
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Figure 3.5: Schematic diagram showing the mechanism by which the back-bonding
of amine-modified silica NPs is reduced by the addition of methyl phosphonate
groups on the silica NP surface (B), compared to silica NPs functionalized just
with amino groups (A). Ref: [54].
10 minutes sonication, and then are spun down with centrifugation at 13000 RCF
for 15 minutes.
3.2.3 Characterization of NIR664 doped NPs
NIR664 doped silica NPs are synthesized by the microemulsion method and
surface modified with the addition of amino and phosphonate groups, as described
above (paragraph 3.2). The main characterization methods being used are dynamic
light scattering (DLS), transmission electron microscopy (TEM), and spectroscopic
techniques.
Dynamic light scattering and transmission electron microscopy charac-
terization
The NP synthesis protocol was improved over time until the NPs samples
matched the requested criteria. To characterize the uniformity of the synthesized
sample, the average diameter and the morphology, two main analysis techniques
were used. A DLS instrument, whose principles have been described in 2.1.2, mea-
sures the average hydrodynamic diameter of the NPs considered as spherical, the
size distribution of the sample and the zeta potential of the NPs solution. TEM is
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a microscope that employs electrons as a imaging beam in place of light, which is
used in conventional microscopes (like transmission light microscopes, fluorescence
microscopes, and so on). A TEM instrument has a resolution much higher than
light based microscopes, being able to image the nanometer scale. Therefore it
shows the actual shapes and dimensions of the NPs samples.
The NPs synthesized with the optimal protocol (already described in section
3.2.2) have an average diameter of 90 ± 15 nm, with a polydispersity index (PDI)
spanning from 0.13 to 0.23 according to DLS analysis. The NP size achieved is
suitable for the project aims, and the low PDI values underline the low polydis-
persity of the samples. The zeta potential is also measured using DLS. The zeta
potential describes the amount of charge present on the surface of the scattering
particles. The further the charge is from zero, either positively or negatively, the
more stable will be the NP. A highly charged surface ensures the repulsion of the
particles between themselves, therefore assuring stability of the particles disper-
sion and low degree of clustering. The NP samples have an average zeta potential
in distilled water of -30 ± 7 mV. A typical DLS size distribution for a sample of
NIR664 doped NPs is shown in figure 3.6.
Figure 3.6: DLS analysis of a sample of NIR664 doped silica NPs, surface modified
with APTMS and THPMP, in water. The zeta average diameter size is 101 nm,
the peak number distribution is at 74 nm and the intensity distribution has a peak
at 112 nm with a width of 47.3 nm. The PDI is 0.143 and the zeta potential -29
mV.
From TEM images NPs are spherical in shape, as it can be seen in figure 3.7.
Moreover the imaging technique confirms the monodispersity of the sample and
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the average diameter obtained from the DLS measurements. NPs are stable for
Figure 3.7: TEM image of the sample which DLS analysis is reported in figure 3.6;
(scale bar = 500 nm).
months in water, with minimal precipitation.
Spectroscopic characterization
The fluorescence properties of NIR664 doped NPs are summarized in figure 3.8,
which shows that the NIR664 dye has an excitation maximum at ≈ 670 nm and
an emission maximum at ≈ 690 nm when embedded in the silica matrix.
To test the stability of dye entrapment inside the silica matrix, the samples
were analyzed soon after the synthesis, and at various times after the synthesis.
NPs are precipitated upon centrifugation at 10000 RPM for 15 minutes, and the
collected supernatant is analyzed in the spectrofluorometer. No fluorescence signal
was found in the supernatant, meaning that dye does not leach out from NPs. No
dye leaching has been observed even after a few months.
To compare the fluorescence intensity of a single dye doped NP with the in-
tensity of a single free dye molecule, measurement of the relative brightness has
been carried out according to the following protocol: a known quantity of NIR664-
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Figure 3.8: Normalized excitation and emission spectra of NIR664 NPs. Excitation
spectrum: λemiss=740 nm; emission spectrum: λexc=640 nm.
iodoacetamide was dissolved in isopropanol and its absorbance was measured in
a UV-VIS spectrophotometer in order to know its exact concentration from the
Lambert-Beer law A =  · C · l. The sample was further diluted to give several
samples.
NP samples were prepared in a similar way: from the absorbance spectrum of
NPs dissolved in water is subtracted the scattering contribution of the NP. The
absorbance value of the dye inside the NP at the peak is so recorded. This value
is used to calculate the dilution ratio to obtain a sample of absorbance ≤0.05 and
other samples with lower concentrations are prepared from it. The employed ab-
sorbance values ensure that the measurements of the fluorescence are in the linear
range.
Synthesized NPs are freeze dried to determine the sample weight (see section 2.1.3
for further details on freeze drying process). The molarity of the sample is cal-
culated using the mass per volume concentration, the density of silica, and the
average diameter obtained by the DLS measurement.
The different dilutions of free dye and of NPs are put in multiple copies in a
multi-well plate for integrated fluorescence measurement with a microarray scan-
ner. In this configuration the values of the fluorescence from NPs and from free
dyes are not comparable [55]. For the wells containing NPs, the illuminated vol-
ume has a different shape and dimension compared to the wells containing free dye
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molecules. This is because the excitation light passing through the well is scat-
tered by the large volumes of the NPs, hence enlarging the illuminated volume (see
figure 3.9). To compensate for this error, when preparing the free dye samples, un-
doped silica NPs are added in solution together with the free dye molecules. These
undoped NPs have to be of the same average size and polydispersity of the NPs
under test. Undoped NPs are used just as scatterers to enlarge the illuminated
volume in the free dye samples, thus ensuring that all the samples have equivalent
scattering properties.
When the integrated fluorescence for all the samples (averaged over the multiple
Figure 3.9: a) Solution of dye doped NPs and b) solution of free dye molecules,
illuminated by a light beam. In the case of a test sample containing scattering
objects (a), the zone illuminated by the incident beam (gray zone) is significantly
enlarged compared to that of the reference solution (b). Ref: [55].
copies) is obtained, these data are plotted versus the concentration in moles per
liter of free dye molecules or of NPs, as shown in figure 3.10.
Having used the same instrument and the same excitation/recording parameters,
it is valid to assume the following:
Fnps
Fdye
=
φnps
φdye
· Anps
Adye
·
(
ηdye
ηnps
)2
(3.1)
where F is the integrated fluorescence, φ the quantum yield, A the absorbance
and η the refractive index of the medium in which the components are diluted.
The extinction coefficient of the dye in solution can be assumed to be the same as
that of the dye when embedded in the silica matrix. The optical path can also be
considered the same for the samples containing NPs and the samples containing free
45
Figure 3.10: Integrated fluorescence for a sample of NIR664 doped NPs in wa-
ter versus NP concentration, and for a sample of NIR664 free dye molecules in
isopropanol versus dye molecule concentration including linear fit of the data.
dye molecules, since undoped NPs have been introduced to compensate scattering
errors. Therefore equation 3.1 can be rewritten as
Fnps
Fdye
≈ φnps
φdye
· Cnps
Cdye
·
(
ηdye
ηnps
)2
(3.2)
Thus, calculating the slope obtained by the linear fit of the integrated fluorescence
versus molar concentration, the equation become
Slopenps
Slopedye
≈ φnps
φdye
·
(
ηdye
ηnps
)2
(3.3)
From this it can be calculated the ratio φnps/φdye that is defined as relative bright-
ness. Using this method it can be shown that the NPs are brighter than a single
molecule dye. The dye doped NPs are brighter than one molecule of NIR664, as
the slope of the linear fit is steeper than that of the free dye samples, as it can be
seen in figure 3.10. From the calculations, the NPs are ≈ 60 times brighter than a
single dye molecule.
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3.2.4 Summary of results
In this section the optimum synthesis of silica NPs doped with a near infra-
red dye obtained after protocol optimization was presented. The initial syntheses
(not described here) were focused on the understanding of the Sto¨ber and mi-
croemulsion processes, by repeating some experiments taken from literature and
by varying parameters. Optimization of the synthesis has been carried out in order
to obtain NPs with the characteristics required for the project, like optimum size,
monodispersity, and high brightness.
NPs obtained in this way remain suspended in solution due to their negative
surface charge (which is measured by the zeta-potential), are stable in water for a
long time, have a diameter variable between 80 nm and 100 nm suitable for the
project and have a low polydispersity. The dye is successfully entrapped in the
silica matrix without any leaching. This is an important point for the stability of
NPs and for their toxicity when used on biological samples.
NP brightness is sufficient to start the experiments on interaction of NPs with
platelets, but further optimization is desired. The aim is to obtain a super bright
label for activated platelets. A super bright label entails a decrease in the limit of
detection, which is a highly desired feature for a diagnostic assay.
3.3 Antibody conjugation to nanoparticles
For this project, NPs have to be modified with a platelet specific tag. Herein,
we conjugate the NPs with an antibody towards specific surface platelet receptors.
An antibody is a gamma globulin protein used by the immune system to identify
and neutralize pathogens such as bacteria and viruses. Each antibody is specific for
a target molecule (called antigen) with a highly specific interaction. A monoclonal
antibody recognizes only one epitope on an antigen, while instead a polyclonal
recognizes multiple epitopes on any one antigen. The basic structural unit of an-
tibodies are similar, with two large heavy chains and two small light chains, as
illustrated in figure 3.11. At the extremity of the protein there is a small variable
region which is the antigen binding site. The unique part of the antigen recognized
by an antibody is called the epitope. These epitopes bind to their antibody in a
highly specific interaction that allows antibodies to identify and bind only their
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unique antigen.
As discussed in 1.2.1, an activated platelet can be distinguished by looking at
Figure 3.11: General structure of an antibody. Ref: adapted from
http://apbrwww5.apsu.edu/thompsonj/Anatomy%20&%20Physiology/2020/2020%
20Exam%20Reviews/Exam%202/CH21%20antibody structure-giant-diagram.htm
the conformational state of its αIIbβ3 receptors. PAC-1 is an antibody, available
on the market, that binds only to the activated form of the platelet glycoprotein
IIb-IIIa complex (or αIIbβ3). It recognizes an epitope on the αIIbβ3 complex
critical for fibrinogen binding. The integrin αIIbβ3 can also be targeted by the
antibody anti-CD41, which binds to every state of the αIIbβ3 receptor.
For the initial development of the assay it was decided to use mouse anti-human
CD41 monoclonal antibody, for the purpose of labelling both resting and activated
human platelets.
3.3.1 Conjugation techniques
Two techniques of antibody conjugation are used. The first is the direct con-
jugation of antibodies to NPs and the second one involves the use of a crosslinker.
In the direct conjugation, synthesized NPs are redispersed in phosphate buffered
saline (PBS) at physiological condition (pH = 7.4), and antibody dissolved in PBS
are added in a concentration which was 3 to 5 times higher than the NP concentra-
tion. The solution is then left under gentle stirring at 4◦C over night. Conjugation
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of antibodies to NPs can take place because of the reaction between carboxyl
groups, -COOH, present on the antibody’s constant region (see figure 3.11) and
amine groups, NH2 present on the NP surface, forming therefore an amide bond.
Using a crosslinker, the reaction between the amine and the carboxyl group
is accelerated and the efficiency increased. 1-Ethyl-3-[3-dimethylaminopropyl]-
carbodiimide hydrochloride (EDC) is a zero-length crosslinker which couples car-
boxyl groups to primary amines. The reaction between EDC and a carboxyl group
Figure 3.12: Chemical structure of 1-Ethyl-3-[3-dimethylaminopropyl]-
carbodiimide hydrochloride (EDC).
creates an amine-reactive intermediate. If this intermediate encounters an amine
a stable bond is formed, otherwise hydrolyzation of the intermediate and regener-
ation of the carboxyl group will take place.
Adding N-hydroxysulfosuccinimide (Sulfo-NHS), which acts as a catalyst, the in-
Figure 3.13: Chemical structure of N-hydroxysulfosuccinimide (Sulfo-NHS).
termediate is an amine-reactive Sulfo-NHS esters with a life-time longer than the
life-time of the intermediate obtained using only EDC. Thus EDC-mediated cou-
pling reactions have greater efficiency. The coupling reaction is represented in
figure 3.14.
For NP conjugation, EDC and Sulfo-NHS are used to bind the carboxyl group
of the antibody with the amine group of the NPs. EDC and Sulfo-NHS are dis-
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Figure 3.14: EDC reacts with a carboxyl group on molecule 1 and an amine-
reactive intermediate is formed. A stable bond is created when the intermediate
conjugates to an amine on molecule 2. The addition of Sulfo-NHS makes the life
time of the amine-reactive intermediate longer. Ref: http://www.piercenet.com/media/
solved in MES buffer in a molar ratio of 1:1. This solution is then added to the
antibody dissolved in PBS, in the same molar ratio. The vial is left for 15 minutes
in incubation at room temperature without stirring. A longer incubation time is
to avoid in order to inhibit further binding between the amine-reactive Sulfo-NHS
esters antibodies and the antibodies themselves (since amino groups are present
in the variable region, as shown in fig. 3.11). After incubation, NPs are added to
the antibody solution, and gently stirred for about 30 minutes. After this time,
the vials are centrifuged at 10000 RPM for 15 minutes to spin down the NPs,
and the supernatant is discarded to remove any unreacted product as well as free
antibodies. The antibody-treated NPs are then resuspended in PBS and stored in
a fridge until usage.
3.3.2 Testing for the presence of antibodies
To determine the presence of the antibody on the NP surface and to quantify
the amount of effectively loaded antibody, the bicinchoninic acid (BCA) protein
assay was used. This is a colorimetric test, based on chemical reactions, able to
determine the concentration of a protein present in a solvent. The test utilizes the
reduction of Cu2+ to Cu1+ by protein when in an alkaline medium, followed by the
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reaction of BCA with the reduced copper ions. The product of this reaction is a
purple colored complex that can be measured by absorption. For a protein concen-
tration not greater than 0.6 mg/ml the intensity of the BCA complex absorbance
is linear with the concentration of the protein under investigation as described by
the Lambert-Beer law.
To perform this test, undoped silica NPs are used in order to avoid any inter-
ference with the measurement of the absorbance from the BCA reaction. Undoped
NPs were synthesized using a Sto¨ber technique. The NPs synthesis protocol was
adjusted to obtain NPs which are similar in size and with comparable zeta poten-
tial values to the dye doped NPs. In this case the Sto¨ber technique is preferable
over the microemulsion because a similar protocol without the dye cannot be ob-
tained. We found in fact that in the developed microemulsion protocol the dye
solution works as a catalyst in the synthesis. Thus a synthesis technique with a
higher yield and less consumption of materials was chosen.
For the NP samples preparation, the NP solution was previously freeze dried
in order to know the concentration of the solid mass per volume. Subsequently, a
volume of solution containing 10 mg of solid mass is used to proceed either with
the direct conjugation technique or with the EDC-mediated conjugation (both
protocols are described in section 3.3.1). For this test we use bovine IgG as an
antibody, which is a standard antibody easily available on the market and largely
used in standard assays. IgG is used in a set of concentrations spanning from 30
µg/ml to 0.3 µg/ml. Bovine serum albumine (BSA) is used as a reference protein
to build the calibration curve. BSA is diluted in concentrations spanning from
250 µg/ml to 0 µg/ml. The test is performed with a BCA assay kit, mixing the
reagents with the standard protein samples and with the NPs samples and leaving
the vials in incubation at 37 ◦C for about 1 hour. Afterwards all the samples
are put in several replicates in a multi-well plate and their absorbance values is
measured at λ = 562 nm with a microarray scanner. The absorbance of the wells
containing BSA are firstly averaged between the replicates and then plotted versus
theirs concentration. In this way is built a linear calibration curve which connects
the measured absorbance with the associated protein concentrations. This trend
is then used to estimate the quantity of antibody present on the NP surface.
The results obtained for the direct conjugation technique of IgG antibody on
silica NPs show a huge variance of the values between the replicates, as illustrated
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by the error bars in figure 3.15, meaning a not highly reproducible antibody loading
efficiency. The amount of antibody effectively loaded for the higher concentration
Figure 3.15: Concentration of IgG antibody conjugated to the NP surface through
direct conjugation technique estimated with a BCA assay. Standard deviations
from 4 replicates are depicted with error bars.
analyzed is around one third of the initial concentration. For IgG concentrations
from 10 µg/ml to 0.3 µg/ml the results cannot be considered due to their large
relative errors.
For NPs treated with ECD and Sulfo-NHS the variance is lower, as shown by
the smaller error bars of figure 3.16. The amount of antibody loaded on the NP
surface is about 40% for a concentration of 30 µg/ml and of 20% for a concentration
of 10 µg/ml, but with a percentage error as high as 36% for the latter one. Again,
the relative errors are too large for the samples with lower concentrations.
This test was repeated using different diluting solvents, like PBS, 1:10 PBS and
water, and all lead to similar results, showing the actual presence of the antibody
on the NPs when treated with either direct or crosslinker mediated techniques as
well as the reproducibility of the results.
To investigate the behavior of the NPs when conjugated with an antibody, AFM
imaging was performed. The samples examined were the NIR664 doped silica NPs
synthesized according to the protocol described in section 3.2.2 and conjugated to
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Figure 3.16: Concentration of IgG antibody conjugated to the NP surface through
crosslinker-mediated conjugation technique estimated with a BCA assay. Standard
deviations from 4 replicates are depicted with error bars.
the antibody anti-CD41 with the techniques described in section 3.3.1. NP samples
were first diluted in water at a low concentration and then dried under nitrogen
flux on glass slides. In figure 3.17 the AFM images of a sample of unconjugated
NPs, and of antibody conjugates one, imaged in contact mode in air, are shown.
From AFM analysis it can be seen that dried NPs tend to aggregate when no
antibody is present on the surface. When the antibody is conjugated to the NPs
(figure 3.17B) there is a decrease in the degree of clustering. NPs conjugated to
anti-CD41 through the crosslinker EDC show a behavior similar to NPs conjugated
directly, resulting in less aggregated samples when deposited dried on a surface.
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Figure 3.17: AFM image of NPs deposited on a glass surface. A) NIR664 doped
NPs unconjugated, B) NIR664 doped NPs conjugated -directly- with antibody
anti-CD41 as described in the text. There is less clustering when NPs are conju-
gated with antibody.
3.3.3 Summary of results
Antibody conjugation on the NP surface has been carried out with two different
protocols. Antibody concentration determination by the BCA method shows the
presence of the antibody on the NP surface. Tests with AFM show the decrease
in NPs clustering behavior when the antibody is present.
In order to check if covalent conjugation has been achieved, experiments involv-
ing the antigen have to be done. In section 4.3.2 will be presented the fluorescence
data obtained when targeting platelets with NPs.
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Chapter 4
Development of a 2D platelet
assay platform
4.1 Introduction
This chapter describes the experiments involving:
• platelets immobilization protocols
• nanoparticle compatibility with blood platelets
• nanoparticle labelling of human platelets.
4.2 Platelet immobilization protocols
To analyze single platelets with techniques like confocal microscopy or atomic
force microscopy, platelets have to be immobilized on a surface. A key issue is to
immobilize and fix the platelets without changing their original condition. This is
indeed a major issue when the analysis is done for diagnostic purposes.
Two protocols have been investigated for platelet immobilization. The first one
involves incubation of PRP on a glass slide; the second one uses whole blood on
glass that has been printed with a fibrinogen pattern.
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4.2.1 Immobilization on glass
The reason why a protocol to immobilize platelets on glass has been developed
is to have a fast and easy technique to prepare the blood sample. The only instru-
ment used is a centrifuge, which is an instrument easy to find in any laboratory.
The immobilization of platelets on glass is based simply on the platelets affinity
to a glass surface: if platelets are left on a glass surface for a time, they will start
to spread and to attach to it.
Blood is obtained and processed as described in section 2.3. After PRP ex-
traction, the platelets are concentrated in a smaller volume, in which platelets can
cluster together. To avoid this happening, the plasma has to be diluted straight
after the centrifugation process. The platelet concentration of a normal healthy
donor gives a concentration of ≈ 150 x 103 platelets per mL. Diluting the plasma
1:3 in HEPES buffer gives a concentration of ≈ 50 x 103 platelets per mL, which is
low enough to avoid clustering, as established by our partners in Royal College of
Surgeons Ireland (RCSI). Diluted PRP is placed on a glass coverslip in incubation
at room temperature and static conditions. From figure 4.1a and 4.1b it can be
seen that an incubation time of 5 or 10 minutes is not enough to have a significant
number of platelets on the glass. In figure 4.1c and 4.1d, representing incubation
times of 40 and 60 minutes respectively, the platelets spread and attach on the
surface; moreover the glass coverage is significantly higher than for shorter incu-
bation times. With a 60 minute time, a high coverage of the surface is achieved
and the platelets are all connected to each other and/or clustered together. For
this reason an incubation time of ≈ 40 minutes was chosen as the optimal time to
obtain good glass coverage and few clusters. After the incubation, the coverslip is
washed three times with HEPES buffer and fixed with glutaraldheyde 1% in wa-
ter or paraformaldheyde (PFA) 3.7% in buffer for 30 minutes, washed again three
times with PBS and then mounted on a glass slide for microscopy analysis.
Variations between different experiments can be explained by the platelet count
of a person being different on each day or by the variable amount of plasma ver-
sus other blood components. The diet of the donor prior to the blood drawing
gives also a source of variability in the platelet properties. Some researchers in
DCU experienced that a vegetarian diet enhances the autofluorescence signal (see
section 5.2), due to the presence of more carotene. Moreover, samples from dif-
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(a) (b)
(c) (d)
Figure 4.1: Platelets from PRP incubated on glass coverslips for a) 5 minutes, b) 10
minutes, c) 40 minutes, and ). 60 minutes. The samples are fixed with glutaralde-
hyde for 30 minutes to enhance platelet autofluorescence and allow, therefore,
confocal analysis without any further dye labelling.
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ferent donors/ethnic groups/physical conditions can be largely different. Another
parameter playing an essential role in the quality of the platelet immobilization
is the way in which the blood is handled. Any shear stress to the platelets when
pipetting or transferring from vial to vial should be avoided. It is also important
the way in which the blood is drawn out from the vein. A larger needle is to be
preferred for smaller shear stress, and the blood suction has to be carried out slowly
and at constant speed. The use of vacuum vials is therefore to be preferred over
manual syringe extraction. Particular care should also be taken in introducing as
small an amount as possible of vein tissue in the blood stream: when platelets get
in contact with exposed subendothelial components, like collagen, the avalanche
activation process starts, as described in section 1.2.1.
In the recent experiments an improvement in the sample quality has been obtained
by discarding the vial of blood that has first been drawn. In the vial that is ex-
tracted first are in fact present all the materials introduced by the needle puncture
(like pieces of skin, molecules of dirt dragged from the skin layer, debris of the vein
wall, and so on).
4.2.2 Fibrinogen printing for platelet immobilization
The second platelet immobilization technique is based on the printing of a
platelet-specific protein on a glass coverslip. The main feature of this technique is
that it allows separation of platelets from whole blood: when whole blood is left
in incubation over the printed glass, platelets are specifically captured from the
platelet-specific protein and adhesion of platelets only is achieved. Another feature
is the possibility to control the confinement of platelets. By using different pattern
sizes, single or multiple platelets can be confined per protein spot. Patterns can
also be made of spots of different shapes, therefore allowing the analysis of how
platelets spread in constrained conditions.
In the early stage of this work, protein patterned surfaces were supplied by our
partners in RCSI. More recently we focused on reproducing these surfaces using
the protocol described in Langmuir [56], and characterizing the printing quality
using AFM, in order to improve and optimize the quality of the patterns.
The first step consists of the fabrication of the stamps. Stamps are made
by pouring PDMS (polydimethylsiloxane) and a curing agent into a patterned
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silicon master. PDMS is treated until complete curing occurs and solid stamps are
extracted from the master. The stamps so obtained are elastic transparent cubes
with less than 1 cm3 of volume.
Before being used for fibrinogen printing, the PDMS cubes are oxidized by
exposure to UV light for 15 minutes. In this way the stamp surface become hy-
drophilic, ensuring a homogeneous spreading of the protein. The platelet-specific
protein used is fibrinogen diluted at 200 µg/mL in PBS and gently sonicated. Fib-
rinogen solution was freshly prepared on the day of printing. A drop of fibrinogen
solution is then left incubating on the stamp for 15 minutes or more and, after
that, stamps are gently rinsed with water and dried under nitrogen flux.
The stamp is placed upside down on a coverslip and left there for 10 minutes to
print the fibrinogen on the glass. Also, the coverslip is previously activated under
UV light for about 30 minutes.
The same stamp can be re-used to create successive prints, with a shorter time
of fibrinogen incubation. To block the uncovered regions of the glass surface, the
printed coverslips are left in a petri dish containing 10 mg/mL of albumin from
bovine serum (BSA) solution until sample analysis.
When the pattern needs to be marked fluorescently, the printing solution is
prepared by adding BSA fluorescein conjugated to the fibrinogen solution. The
concentration of BSA used is 25 µg/mL. The printing process is then carried out
minimizing the light exposure. The pattern is labelled in green using the fluores-
cent protein (see the spectra for fluorescein in figure 4.2) and can be visualized
upon excitation with a 488 nm laser light beam.
Figure 4.2: Normalized absorption and emission spectra for fhe BSA fluorescein
conjugated dye.
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Characterization of the fibrinogen pattern
The first attempts at protein printing had produced a patchy pattern or no
pattern.
After several trails it was found that the main key for good printing is the way in
which the stamp is handled. Great care has to be used when placing the stamp
on the glass, moving it in the direction of the line normal to the glass surface and
exerting a pressure just enough to make all the PDMS cube adhere to the glass. An
extra pressure can push the pillars of the stamp in a way in which the fibrinogen
contained in the inner-spaces of the pillars drop out. Extra care has also to be used
when removing the stamp from the glass: the cube has to be gently peeled from
the glass. A further improvement in the quality of the pattern was also achieved
using fibrinogen solutions that had been slightly sonicated before deposition it on
the PDMS stamp.
The printed pattern was not always produced successfully even when taking
account of all these tips. Sometimes on the glass there could still be some areas
with no pattern, with partial patterning, or with different fibrinogen concentra-
tions. A good practice is, therefore, to always prepare multiple samples.
The printing quality was assessed with fluorescence microscopy and AFM. Flu-
orescence microscopy allowed to check the whole appearance of the pattern and
AFM was used to investigate the height of the deposited fibrinogen layer and the
uniformity of the protein within single spots.
For fluorescence imaging the pattern was composed of fibrinogen mixed with
BSA conjugated to fluorescein (as described in the previous section). In figure 4.3
an example is shown of a typical printed surface, mostly homogeneous but with
some small defects in some spots.
The most difficult shapes to reproduce were the 2 µm sized spots, which often
were not present, partially or even totally. Nevertheless after a long practice it was
possible to obtain good quality 2 µm sized patterns, like those shown in figure 4.4.
The fibrinogen could be printed in different shapes, circles, squares and teardrops.
In figure 4.5 is shown the printing from a stamp containing all the three shapes in
different dimensions.
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Figure 4.3: Fluorescence image of a printed pattern of fibrinogen. 6 µm and 12 µm
circular spots are visible together with the crosses used for reference. The printing
is homogeneous but with some defects. The image is obtained using a 10X object
in air and completely opening the pinhole aperture of the confocal microscope.
Figure 4.4: Confocal image of 2 µm fibrinogen spots. The image is obtained with
a 60X oil immersion objective lens and pinhole aperture of 1 Airy unit.
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Figure 4.5: Confocal image of mixed shaped fibrinogen printed spots. The image
is obtained with a 60X oil immersion objective lens and pinhole aperture of 1 Airy
unit.
To investigate the nano-scale quality of the pattern, fibrinogen-printed cover-
slips are imaged with atomic force microscopy. AFM is a very powerful tool for
high-resolution surface mapping. For our purposes it is a key component in the
analysis of the homogeneity of the fibrinogen and the estimation of the number of
layers deposited.
The imaging is carried out directly on the printed coverslip without any prior
surface treatment and imaged in PBS to maintain the proteins in their natural
state. The tip used is a silicon nitride probe specific for fluid tapping mode imag-
ing, with resonance frequency of 65 kHz and force constant 0.35 N/m. The tip is
never driven at a speed higher than 15 µm/s to achieve a high resolution and to
preserve the integrity of the sample.
Figure 4.6 displays the 2-D and the three dimensional surface plots of a printed
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pattern of nominal 6 µm circular spots. It can be seen that the printed areas are
(a) (b)
Figure 4.6: a) AFM image of four 6 µm circular spots of fibrinogen and b) its 3D
projection. The image was performed in tapping mode in liquid with tip speed of
10 µm/s.
actually circles regular in periodicity, with no fibrinogen printed outside of the
pattern. A close up of a single spot performed at very low tip speed enables to
view the profile of the deposited fibrinogen layer. The example in figure 4.7 shows
a nominal 6 µm diameter spot. From the analysis of its height profile it can be seen
that the actual diameter is around 5.5 µm, and the average height is around 2.5
µm. This corresponds to several layers of deposited fibrinogen, in fact the mean
height of the fibrinogen molecules is 3.4 nm and the mean length is 65.8 nm [57].
The height of the fibrinogen layer deposited can vary according to the concen-
tration of fibrinogen solution used for printing, the pressure exerted on the stamp
and in general from the way in which the person performs the printing. The lowest
height of deposited fibrinogen being imaged is 8 nm, which corresponds to a couple
of layers of molecules.
The fibrinogen-printed surfaces so created are used for platelet immobilization.
Whole blood is incubated on the coverslip for 30 minutes in rocking condition and
then washed with HEPES.
A preliminary analysis of the capture efficiency can be performed using confocal
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Figure 4.7: AFM image of a single 6 µm circular stamp and its height profile along
a line. The image was performed in tapping mode in liquid with tip speed of 1.5
µm/s.
microscopy. The backscattered light signal enables imaging of the fibrinogen pat-
tern. In figure 4.8 is shown a confocal image of a sample of platelets (fixed with
a solution of 1% (w/v) glutaraldehyde in water) deposited on a fibrinogen printed
glass slide with pattern of squares, circles and tear drops of different sizes. The
printing is not neat, showing some protein deposited outside of the pattern. This
was due to an excessive pressure exerted during the stamp printing. Platelet cap-
ture can be monitored by looking at the autofluorescence which was enhanced by
the fixative.
Here it can be seen that platelets specifically bind to the fibrinogen pattern which
provides the spatial control of cell deposition required for diagnostic purposes.
Other examples of platelets captured on fibrinogen patterns will be shown in
section 5.4.
64
(a) (b)
Figure 4.8: WB incubated over a micro-patterned fibrinogen pattern, washed and
then fixed with glutaraldehyde 1% (w/v). a) Backscattering image of the coverslip,
clearly displaying in dark grey the fibrinogen pattern. b) Confocal fluorescence
image showing the platelets autofluorescence enhanced by the fixation. Platelets
are specifically captured by the fibrinogen and adhere to the pattern. Images
obtained with a 488 nm argon laser line.
4.2.3 Summary of results
Two different protocols have been successfully optimized for platelet immobi-
lization.
Immobilization on glass is preferred when a simple way of sample preparation is
needed. Fibrinogen-patterned surfaces are chosen whenever it is required to im-
mobilize platelets in a known shape and in a reproducible manner. AFM and
confocal imaging of fluorescence or autofluorescence signals are efficient tools to
characterize the surfaces.
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4.3 Nanoparticles-platelet interaction
4.3.1 Compatibility of NPs with platelets
One fundamental point in developing an assay for diagnostic purposes is that
the materials and methods employed do not interfere with the analyte to be mea-
sured, monitored or labelled.
In this project, NPs are to be used to quantify the number of activated platelets
present in a sample of fresh blood. If the percentage is over a certain threshold,
the patient is considered to be in risk for heart attack or stroke, as explained in
section 1.2, and a specific medical treatment has to take place. To have a correct
diagnosis it is therefore essential that NPs do not induce any aggregation or alter
the functionality of the platelets.
Two tests have been performed to assure the NPs’ biocompatibility with platelets:
aggregometry test and flow cytometry analysis.
Platelet aggregometry test
An aggregometry test is performed in order to see if platelet aggregation kinetics
are influenced by the presence of NPs. The instrument used was an aggregometer
that measures the transmitted light of a platelet rich plasma (PRP) sample during
platelet aggregation, as explained in section 2.1.4.
The experiment is performed as follows: whole blood, PRP, and platelet-poor-
plasma (PPP) are obtained, as described in section 2.3. In aggregometry analysis
the vials containing fresh blood must first stand for 30 minutes after collection. In
this time the platelets regain their responsiveness. Blood samples must then be
tested within 3 hours of collection to avoid deterioration of plasma and platelet
procoagulants [48]. PPP is inserted in the aggregometer as a reference sample.
Before adding NPs to the PRP samples, a check is made to see how platelets
aggregate and how much of the activator has to be used to obtain a standard
aggregation profile. The activator used is adenosine diphosphate (ADP), which
induced platelet aggregation (for further details see section 1.2.1).
From figure 4.9a it can be seen that when no agonist is added, the percentage of
aggregation remains stable at 0%. A concentration of 6.5 µl = 5 µM of ADP gives
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a normal aggregation curve. A concentration of 13 µl = 10 µM of ADP could
result in clots, like in the curve recorded. Attention has to be paid to the agonist
addition time: if the sample is left for too long in the measuring well, it can get
damaged by the high speed of stirring. This can induce some shape change in
the platelets that would alter the aggregometry test. Good practice is to add the
agonist within the first 1-2 minutes after the measurement had been started.
(a) (b)
Figure 4.9: a) Aggregometry profile of 250 µl of PRP with different amounts of
agonist (ADP). Channel 1, no agonist added; channel 2, 5 µM; channel 3, 10 µM.
b) Aggregometry profile of 250 µl of PRP with different samples added. Channel
1, 20 µl of ethanol; channel 2, 20 µl of NIR664 doped NPs in ethanol; channel
3, 20 µl of undoped NPs in ethanol synthesized in microemulsion; channel 4, 20
µl of undoped NPs in ethanol synthesized by the Sto¨ber method. To each of the
channels 5 µM of ADP is added following channel numerical order.
If the NPs are dispersed in ethanol, the aggregation of platelets cannot take
place, as shown in figure 4.9b. The NPs have to be dissolved either in water, PBS,
or HEPES buffer.
To see if NPs influence the platelet aggregation profile, four samples with dif-
ferent concentrations of NPs dissolved in water were prepared. From figure 4.10 it
can be seen that the general aggregation trend is similar for all the samples inde-
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pendent of NP concentration. Channel 2, with the lower amount of NPs, presents
Figure 4.10: Aggregometry profile of 250 µl of PRP with added:(channel 1) 20 µl
of PPP and 0 µl of NPs , (channel 2) 15 µl of PPP and 5 µl = 85 nM of NPs,
(channel 3) 10 µl of PPP and 10 µl = 170 nM of NPs, (channel 4) 0 µl of PPP
and 20 µl = 340 nM of NPs. After 1 minute to each of the channels, following the
channel numerical order, it is added 6.5 µl = 5 µM of ADP.
a different behavior probably due to some damage induced by the stirring (since
it had the same noisy profile even before the aggregation had started), but shows
a similar aggregation trend as channel 1, where there are no NPs mixed with the
PRP. Channel 3 and 4, with 170 nM and 340 nM respectively of NPs, have a final
aggregation of 68% and of 72%, that differs from the aggregation reached by the
reference sample (=79%). This variance is not significant, since a difference greater
than ≈15% in the aggregation is considered to indicate an abnormal aggregation.
The data obtained from the aggregometry test shows the biocompatibilty of
the silica NPs NIR664-doped with the platelets: the NPs do not alter the platelet
aggregation properties.
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Flow cytometry analysis
Flow cytometry, described in section 2.1.5, can be used to record the fluores-
cence arising from platelet activation products. With flow cytometry it can be
shown whether or not the addition of NPs to platelet rich plasma (PRP), or to
whole blood (WB), affects the activation of platelets.
In this flow cytometry experiment platelet activation status is monitored by
looking at the conformational status of the platelet receptor αIIbβ3, and by de-
tecting the presence of P-selectin expressed on the platelet surface. These two
markers are a peculiarity of activated platelets only, as described in section 1.2.1.
To target the open conformation of αIIbβ3, PAC-1 antibody, which binds to the
fibrinogen binding site of the αIIbβ3 complex is used. To target the P-selectin
exposed on the platelet surface an antibody towards P-selectin was used. When
these two antibodies are conjugated with two different dyes they can be used to
fluorescently label activated platelets. Choosing two dyes with overlapping exci-
tation spectra but different emission regions allows the sample to be excited by a
unique wavelength and permits the detection of the two different antibodies in two
separate channels.
The dyes chosen for the experiment are fluorescein FITC and R-phycoerythrin
(PE). The former has an absorption maximum at 495 nm, and the latter at 488
nm. Both dyes can be efficiently excited with an argon laser (excitation wavelength
488 nm). The emission of the two dyes can be easily separated using optical filters,
since FITC has an emission maximum at 518 nm in the green region of the visible
spectrum, and the PE emission is in the yellow/orange part, with emission peak
at 578 nm.
PAC-1 antibody is conjugated with FITC, and anti-P-selectin is conjugated with
PE.
The unique feature of flow cytometry is the ability of measuring the fluorescence
per single cell (or particle). This contrasts with spectrophotometry in which the
percent absorption and transmission of specific wavelengths of light is measured
for the bulk volume of the sample.
The flow cytometry experiment of the data reported in table 4.1 was performed
as follows: the whole blood (WB) and PRP obtained as detailed in section 2.3, are
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divided into several vials, each of them of 250 µl to which a 20 µl volume of NPs is
added. The samples are left in incubation for 30 minutes in different conditions: at
room temperature in static conditions or on a rocking table, or at 37◦ C in static
conditions. WB or PRP samples with no added NPs are prepared and incubated
similarly, adding 20 µl of PBS to match the volumes. Meanwhile, the flow cytom-
etry tubes are prepared with the antibodies towards platelet activation products,
anti-P-selectin-PE and PAC-1-FITC, diluted in HEPES buffer. Some additional
tubes are prepared as control samples with IgG, an antibody not conjugated to
any dye.
When the NP incubation is finished, a volume is transferred from the incubation
vials to the tubes containing the antibodies. The platelet activator TRAP (throm-
bin receptor-activated peptide) is then added at exact time intervals to the part
of the samples where activation is induced. To the remaining tubes it is added
HEPES buffer. After exactly 10 minutes the reaction of the activator is stopped
by dilution with a large volume of HEPES buffer. The samples are then inserted
in the flow cytometer one at a time, starting with the control sample.
The control samples, composed of WB or PRP with non-fluorescent IgG, are
the negative control. These control samples are used to locate the platelet events in
the histogram of Side Scatter (SS) intensity versus Forward Scatter (FS) intensity
as depicted in figure 4.11. This can be done since the average size and granularity
of the platelets are well known values.
The control sample is also used to set a threshold to cut out noise events. Since
the negative sample has no fluorescence signal, all the collected fluorescence events
are noise.
The fluorescence signals collected on each PMT are plotted in a one-parameter
histogram. These histograms display the number of counts versus fluorescence in-
tensity.
The samples are then processed and for each of the fluorescence channels it is
recorded the percentage of platelet fluorescence events and the mean fluorescence
intensity of these events. On the first fluorescence channel it is recorded the fluo-
rescence from PAC-1-FITC, and on the second the fluorescence arising from anti-
P-selectin-PE. The data are summarized in table 4.1.
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Flow cytometry values for distinctive activation products of platelets
Incubation Activator Sample
PAC-1 PAC-1 P-selectin P-selectin
percentage of mean fluorescence percentage of mean fluorescence
events of events events of events
Room
none
PRP 0.30 1.06 3.01 1.00
temperature PRP + NPs 0.40 1.07 3.04 1.00
static
TRAP
PRP 69.33 8.74 73.70 6.38
conditions PRP + NPs 69.27 8.58 72.46 6.10
none
PRP 0.82 1.03 3.12 1.00
37◦C PRP + NPs 0.59 1.02 3.33 1.00
static
TRAP
PRP 69.81 5.19 72.19 4.55
PRP + NPs 70.67 5.35 74.12 5.09
Room
none
WB 0.42 1.13 1.63 1.00
temperature WB + NPs 0.87 1.15 2.29 1.00
static
TRAP
WB 65.12 7.70 68.32 5.42
conditions WB + NPs 64.52 7.50 70.48 5.88
none
WB 0.28 1.09 1.02 1.00
37◦C WB + NPs 0.64 1.09 1.51 1.00
static
TRAP
WB 31.41 3.25 49.84 2.49
WB + NPs 32.67 3.28 50.28 2.55
Room
none
WB 0.55 1.13 2.26 1.00
temperature WB + NPs 0.73 1.19 2.37 1.00
rocking
TRAP
WB 29.87 3.40 54.60 3.72
table WB + NPs 49.98 5.88 70.26 7.10
Table 4.1: Table summarizing the flow cytometry data of distinctive activation
products of platelets, obtained using PRP or WB with or without the presence of
NIR664 doped NPs. The values obtained when NPs are present are close to the
one obtained when NPs are absent for all the incubation conditions, meaning a
insignificant influence of the NPs on the platelets. In the text the description of
the experiment can be found.
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Figure 4.11: Histogram of SS versus FS for the control sample of WB incubated
at 37◦C in static conditions. The area outlined in R1 is where platelet events are
located. The perimeter of R1 is a pre-known data which is reloaded for each of
the flow cytometry experiments. It is drawn knowing the scattering properties of
the platelets (size, granularity,..). No NPs are present in the control sample to not
influence the settings for the experiment.
The percentage of fluorescence events originating from PAC-1 and anti-P-
selectin is related to the degree of platelet activation of the sample.
From the results it can be seen that the percentages of PAC-1 and anti-P-selectin
events are not significantly modified by the presence of NPs. In fact, the data
obtained for samples of only PRP are similar to the data for PRP with added
NPs. For incubation at room temperature in static conditions it can be seen that
NP presence in PRP gives a percentage of PAC events of just 0.40% and 3% of
P-selectin. These values are insignificant compared to the values obtained when
activation is induced on PRP for the same incubation condition, which are 69% for
PAC and 74% for P-selectin. Moreover, the values obtained for samples with NPs
when the activator TRAP is present are close to those obtained in the absence of
NPs and with TRAP. This is valid in all the investigated conditions. For whole
blood samples the data do not suggest any change in platelet behaviour when NPs
are present, except for the incubation on the rocking table, where the percentage
of PAC and P-selectin events are significantly increased by the presence of NPs.
This can perhaps be due to shear forces exerted by the NPs during the dynamic
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incubation rather than from the NPs presence. In fact for incubation in static
conditions this enhancement is not observed. From these data it can be deduced
that NPs do not induce a change in platelet functionality.
4.3.2 Labelling of platelets by NPs
In this section the results obtained from labelling platelets using NIR664 doped
silica NPs synthesized, as described in section 3.2 are shown.
The surface on which the platelets are immobilized consists of fibrinogen de-
posited on a glass slide in a micro-pattern. Platelets are captured on the micro-
patterned fibrinogen, a platelet-specific protein, and, therefore, confined on specific
areas. In the early stage of this work these surfaces have been provided by Royal
College of Surgeons in Ireland from Miss Lopez-Alonso and Dr. Basabe-Desmonts,
and later on prepared “in-house” according to the protocol developed by Basabe-
Desmonts and others [56]. The fibrinogen printing technique and the characteri-
zation of the patterned surfaces is described in section 4.2.2.
The protocol for labelling platelets with NPs is divided in 4 steps. First,
platelets are immobilized on the fibrinogen patterned glass. Second, platelets are
incubated with NPs conjugated to anti-CD41 to test NP labelling efficiency. Third,
as a reference platelets are incubated with an antibody towards the surface platelet
receptor GPIX. Fourth, glass slides are examined under confocal microscopy to val-
idate the labelling.
Anti-CD41 is an antibody specific for platelets that bind to all the conformational
forms of the integrin αIIbβ3. NPs are conjugated to anti-CD41 as described in
section 3.3. Anti-GPIX is used as a reference to fluorescently mark and locate
the platelets. The GPIX antibody employed is conjugated with the fluorophore
fluorescein (FITC).
The fibrinogen pattern is printed on a microscope coverslip, which is kept in a
petri dish submersed in PBS until it is used. Fresh blood is obtained, as described
in section 2.3. A volume of whole blood is added to the coverslip and the petri
dish is placed on a rocking table. After 30 minutes of incubation, the coverslip
is washed three times with HEPES, and then a solution of NIR664 doped NPs
conjugated with anti-CD41 is added. NPs are left in incubation on the coverslip,
on a rocking table, for 30-60 minutes, and then the glass is washed 3 times with
HEPES buffer. A further 30 minutes incubation on a rocking table takes place for
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a solution of anti-GPIX-FITC, followed by 3 washes with HEPES buffer. To fix
the glass slide, a solution of paraformaldehyde 3.7% (w/v) in water is added to the
sample for 15-60 minutes, and then washed away with PBS or HEPES buffer. The
sample so obtained can be kept for few days in darkness in a petri dish immersed
in PBS, or glued on a glass slide with a mounting medium, until confocal analysis
takes place.
Samples prepared in this way are investigated through confocal microscopy
(principles explained in 2.1.1), using a Zeiss LSM 510 Meta laser module confocal
microscope with an excitation wavelength of 488 nm of an argon ion laser and of
633 nm of an helium-neon laser, and a 63X magnification oil objective (N.A.=1.4).
The 488 nm laser light is used to excite the fluorophore FITC, which has an ab-
sorption maximum at 495 nm. Its fluorescence signal is collected through reflection
from a dichroic beam splitter (545 nm) and the transmission of a band pass filter
505-575 nm. NIR664 NPs are excited with the 633 nm laser light, and the fluo-
rescence separated through the transmission of a dichroic beam splitter (545 nm)
followed by a low pass filter 650 nm placed in front of the second PMT. In this
way it is possible to record the x-y fluorescence data obtained with two different
excitation sources and relative to two different labels, the membrane label FITC
conjugated anti-GPIX antibody in the green part of the spectrum and the NPs, in
the near infra-red part of the spectrum.
In figure 4.12 confocal images from a sample labelled with anti-GPIX-FITC
and with NIR664 NPs-anti-CD41 (direct conjugation method) are shown. The
platelets are confined in fibrinogen patterned spots and are visible due to the
FITC-antibodies which stain the membrane of platelets. From the fluorescence
signal arising from NPs, it can be seen that NPs do not label the platelet mem-
brane in the same way as anti-GPIX is doing. NPs are collecting into clusters
located on platelet membranes. Unfortunately, it is impossible to quantify the
number of NPs on the platelet surface, because the minimal resolution relates to
the focal volume. For our system the lateral resolution is ≈ 300 nm. This means
that a single “signal” pixel can contain more than one NP.
Control samples have been prepared following the same protocol but using NPs
that are not conjugated with any antibody. In figure 4.13 the image obtained from
fluorescence light between 505 and 545 nm, which corresponds to the signal from
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Figure 4.12: Confocal images of platelets from WB labelled with anti-GPIX-FITC
(green emission) and with NPs (NIR emission) conjugated to anti-CD41 captured
on a micro-printed fibrinogen pattern. The left panel shows the green fluorescence,
the right one the NIR fluorescence. Average of 4 scans; λexc = 488 nm and 633
nm; pixel time 6.40 µs; pinhole diameter of 1 Airy unit.
anti-GPIX-FITC is shown, on the left and, on the right, the image obtained from
the fluorescence collected in the near infra-red part of the spectrum is shown. Since
in this case NPs are not supposed to attach to the platelet surface and should get
removed during the washing, the collected signal of the near infrared light should
be dominated by noise. This actually does not happen and the signal from the
NPs is greater than the noise. Some clusters of NPs are still present even when
NPs have no antibody on their surface. NPs clusters are located especially in the
inner spaces between the platelets and in a few spots outside the platelets, showing
some non-specific attachment. Comparing the control results with the NPs-anti-
CD41 labelled samples it can be seen that the degree of NPs specificity to target
human platelets is not enhanced by the direct conjugation of platelets specific anti-
body on the NPs. A visual comparison of the two cases is presented in figure 4.14.
The next experiments were done using NIR664 NPs conjugated to the antibody
through the cross-linker EDC, as described in section 3.3. When NPs-anti-CD41
are incubated with the platelets (see figure 4.15), NPs still collect in clusters, as
happened in the previous experiment. The percentage of clusters per platelet is
slightly higher when using the crosslinker compared to when using the direct con-
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Figure 4.13: Control sample. Confocal images of platelets from WB labelled with
anti-GPIX-FITC (green emission) and with NPs (NIR emission) not conjugated
with any platelet-specific antibody captured on a micro-printed fibrinogen pattern.
The left panel shows the green fluorescence, the right one the NIR fluorescence.
Average of 4 scans; λexc = 488 nm and 633 nm; pixel time 6.40 µs; pinhole diameter
of 1 Airy unit
(a) (b)
Figure 4.14: RGB compositions of a) images displayed in figure 4.12 relative to the
labelling from NPs-anti-CD41, and of b) images displayed in figure 4.13 relative
to the control samples. No significant difference can be seen. Green channel:
fluorescence from platelet membranes stained with FITC; red channel: fluorescence
from NIR664 NPs.
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jugation technique (≈ 3% more), but still not satisfactory enough for the aim of
the project. The control sample, in which NPs do not have any antibody conju-
Figure 4.15: Confocal images of platelets from WB labelled with anti-GPIX-FITC
(green emission) and with NPs (NIR emission) conjugated to anti-CD41 through
the cross-linker EDC, captured on a micro-printed fibrinogen pattern. The left
panel shows the green fluorescence, the right one the NIR fluorescence. Average
of 4 scans; λexc = 488 nm and 633 nm; pixel time 6.40 µs; pinhole diameter of 1
Airy unit.
gated, is shown in figure 4.16. In both figures 4.15 and 4.16 the imaged area is a
region of the coverslip where the fibrinogen is printed on a wide area. The area is
shaped as a cross with arm dimensions of ≈ 40 µm X 15 µm. Since the platelet
density is higher in the wider regions, possibility of having unremoved material in
the inner spaces between the platelets is higher. The control and the samples can
be visually compared in figure 4.17. The percentage of NP signals (coded in red)
on the platelets surface is slightly higher for the NPs conjugated with anti-CD41
but still not satisfactory.
The results obtained are still far from the optimal, which is to obtain a uniform
NP staining of the whole platelet membrane. The aim is to build up a platform that
works as an effective tool to target platelets. No significant labelling of platelets by
the antibody conjugated NPs was achieved. The antibody conjugated NPs have
a very low specifity on the platelet membrane and they bind to the membranes
in a degree similar to what unconjugated NPs do. More studies on the effective
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Figure 4.16: Control sample. Confocal images of platelets from WB labelled with
anti-GPIX-FITC (green emission) and with NPs (NIR emission) not conjugated
with any platelet-specific antibody captured on a micro-printed fibrinogen pattern.
The left panel shows the green fluorescence, the right one the NIR fluorescence.
Average of 4 scans; λexc = 488 nm and 633 nm; pixel time 6.40 µs; pinhole diameter
of 1 Airy unit.
conjugation of antibody to NPs are required.
A further analysis of the cell signal also needs to be done. A contribution to the
signal arising from the intracellular part of the platelets was found. This contri-
bution is more visible for the images relating to the fluorescence collected through
a low pass filter 650 nm (near infra-red channel), where the signal to noise ratio is
lower compared to the images for the green wavelengths. Initially it was assumed
that this signal could be associated with some degree of NP penetration through
the platelets membrane. In later studies a similar background signal has been
found also on samples prepared using whole blood or PRP without any addition
of NPs. The intracellular signal seems therefore arise from platelets themselves. A
deeper analysis of the fluorescence signal of unlabelled platelets will be shown in
section 5.2.
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(a) (b)
Figure 4.17: RGB compositions of a) images displayed in figure 4.15 relative to
the labelling from NPs-anti-CD41 (antibody conjugation through EDC), and of
b) images displayed in figure 4.16 relative to the control samples. The percentage
of NP signals on the platelet surface is slightly higher when NPs are conjugated to
anti-CD41 through the crosslinker EDC. Green channel: fluorescence from platelet
membranes stained with FITC; red channel: fluorescence from NIR664 NPs.
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4.3.3 Specificity of antibody conjugated NPs
When using the NPs to label the platelets, a satisfactory uniform staining
of the whole membrane could not be achieved. Moreover, data obtained using
NPs conjugated with the antibody through the direct conjugation technique are
not largely different from those obtained when using a cross-linker. The degree
of labelling achieved suggests that covalent antibody conjugation has not been
achieved or only partially achieved.
The BCA assay and the AFM test presented in section 3.3.2 show the presence
of the antibody on the NP surface, but do not give any information about the
nature of the bond. If the bonding with the antibody is electrostatic, the antibody
is only adsorbed on the NP surface. For NPs with adsorbed antibodies the labelling
of an external target is not efficient: this bond is not as strong as a covalent one
and the NPs can be washed away during the washing steps.
For the two antibody conjugation techniques employed it cannot be excluded
that the nature of the bond is electrostatic. The carboxyl groups (COOH) on the
antibodies are negatively charged and the O− is not a good leaving group. The
creation of a covalent bond with an amine is very unlikely unless in the presence of
a catalyst or of a heat source. In the direct conjugation technique no other chemical
is used and no heat source can be employed so as not damage the antibody. In
these conditions carboxylic acids can react with amines to form ammonium salts,
creating therefore an electrostatic bond.
For the cross-linker conjugation technique an unsuccessful conjugation can oc-
cur if the amine-reactive antibodies react with amino groups of the other antibodies
or of the NP surface.
AFM was used as a tool to investigate the actual specificity of the antibody con-
jugated NPs towards the antigen. If the specificity of the antibody conjugated NPs
is comparable to the specificity of unconjugated NPs, the nature of the chemical
bond achieved cannot be covalent.
In this experiment fibrinogen is used as an antigen and the NPs are conjugated
to the antibody towards the fibrinogen. The system is kept simple, not involving
any other elements than the antibody NPs and the antigens, therefore free of in-
teraction with third materials. NPs are conjugated to anti-fibrinogen through the
crosslinker EDC, as described in section 3.3. Fibrinogen is printed in a pattern on
a glass cover slip following the protocol described in section 4.2.2. The fibrinogen
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solution is prepared in a concentration of 100 µg/mL and mixed with 25 µg/mL of
albumin from bovine serum (BSA) conjugated to the fluorophore fluorescein. By
mixing the fibrinogen with a fluorescently labelled protein the pattern produced is
fluorescently stained. The concentration of BSA used is low enough to not alter the
fibrinogen printing quality, as already assessed by our partners in RCSI. The NPs
are undoped to avoid any fluorescence interference with the imaging of the pattern.
Antibody-conjugated NPs are incubated on the fibrinogen surfaces for 30-45
minutes in static conditions and then washed out three times with HEPES buffer.
The glass is then imaged using an AFM in a liquid environment, using a silicon
nitride probe in tapping mode. An inverted microscope mounted on the AFM
stage allows the acquisition of fluorescence images of the sample directly on the
AFM platform. The fluorescence arising upon excitation of a mercury lamp with
band pass filter of 460 - 495 nm is filtered through a band pass 510 - 550 nm filter
and then recorded with a camera. In this way the protein printed pattern can be
visualized in a fluorescence image, as shown in figure 4.18b. The AFM image of
Figure 4.18: a) and b): undoped NPs conjugated to anti-fibrinogen and incubated
over a fibrinogen pattern mixed with fluorescein conjugated BSA. a) AFM image,
showing in white the NPs and in light brown the fibrinogen pattern; b) correspond-
ing fluorescence image, showing in bright the printed pattern. c) Section of the
AFM picture along the line of picture a), which intersects a 1.5 µm long and 10
nm thick fibrinogen layer with attached a single nanoparticle of 80 nm.
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the same area is presented in figure 4.18a. The area coded in light brown is the
fibrinogen pattern, as it perfectly matches the fluorescence data of figure 4.18b.
The lighter spots are the antibody-NPs attached to the antigen surface. In figure
4.18c is shown a section of the AFM data taken along the line of figure 4.18a. As
it can be seen, the fibrinogen has been deposited in an even layer with average
thickness of 10 nm. The spike in the profile indicates a NP of size 80 nm.
From the comparison of the fluorescence channel, the AFM channel, and its
profile it can be seen that antibody conjugated NPs bind to the fibrinogen pat-
tern with a high specificity. Therefore the targeting of the antigen looks successful.
The control experiment employs undoped NPs not conjugated to any antibody
and a fibrinogen printed surface prepared as previously described. The sample
after the washing should consist only of the fibrinogen pattern with few or none
NPs. The AFM image of the control sample is presented in figure 4.19. Once
Figure 4.19: AFM image of undoped NPs (lighter spots) incubated on fibrinogen
circular spots (light brown). NPs show a high specificity to the fibrinogen even if
no antibody is present on the NPs surface.
again the fibrinogen pattern can easily be recognized in patterns (full circles in
this case). Unsuccessfully, NPs do not get removed from the washing and they are
still present over the pattern. NPs show a high specificity to the pattern even if
no antibody is present on their surface.
These results clearly demonstrate that the antibody conjugation technique used
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is not efficient enough to bind the antibody covalently to the silica surface, as
similar results are obtained with or without antibody. Moreover, this experiment
shows the necessity of an improved alternative surface chemistry of the NPs. In
figure 4.19 infact can be seen that it is the plain silica surface itself which reacts
and binds to the proteins. This feature can give rise to non-specific labelling when
introducing antibodies on the NP surface.
4.3.4 Summary of results
Aggregometry and flow cytometry tests show the biocompatibilty of the dye
doped silica NPs with the platelets. The presence of NPs does not alter platelet
aggregation properties or induce change in platelet functionality.
Labelling experiments with antibody-conjugated NPs show an unsatisfactory
labelling of the platelet membrane with a specificity comparable to the unconju-
gated NPs, as confirmed later on from NPs specificity tests. These results are
fundamental in the project to understand that different alternative protocols of
antibody conjugation have to be investigated. The experience obtained also sug-
gests a deeper understanding of the nature of the antibody bond to the NP surface
before proceeding with the platelet labelling. For more successful results, the work
has to be integrated with a complete characterization of antibody conjugation,
including immunoassays and binding tests where only the antigen is present.
The research is currently carried on with different antibody conjugation pro-
tocols from other researchers involved in the project. So far a higher and more
specific degree of platelets labelling is obtained using dendrimers as linkers between
the antibody and the NP surface.
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Chapter 5
Characterisation of novel features
of platelet physiology
5.1 Introduction
This chapter describes the experiments involving:
• platelets autofluorescence
• fluorescence assays on platelets in different activation conditions
• morphology of platelets in different activation conditions.
5.2 Platelet autofluorescence
5.2.1 Overview of biological autofluorescence
The enhanced brightness of NPs seeded with fluorescent molecules provides
an attractive tool for the identification of both entire cells and sub-cellular fea-
tures such as the location and concentration of specific membrane proteins. NPs
containing surface-immobilized antibodies specific to the extracellular portions of
transmembrane receptors would therefore act as a single step fluorescence mem-
brane receptor reporter.
This section investigates the background to be expected when analyzing platelet
samples using fluorescence-based techniques, like confocal microscopy. Under-
standing the endogenous fluorescence expected from untreated human platelets
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provides information essential when engineering assays to report fluorescence sig-
nals significantly above the “contaminating” background. Fluorescence from a
sample can be present when the sample has been labelled with an exogenous flu-
orophore. Often biological samples present a fluorescence signal even when not
labelled. This fluorescence signal is called autofluorescence and comes from en-
dogenous chromophores already present in the biological sample. In figure 5.1
the excitation and emission spectra of the most common endogenous fluorophores
are shown. Some of the most common sources of autofluorescence are aromatic
amino acid residues like tryptophan, tyrosine and phenylalanine. These are mostly
concentrated in mitochondria and can also be present in cell cytoplasm which
also contains NADH and NADPH, fluorescent molecules which are involved in the
methabolism. Flavins are also autofluorescent; riboflavin FAD and FMN, which
are mostly bound to enzymes, are concentrated in mithocondria, present in the
cytoplasm as well as in the outer membrane. A prominent source of autofluores-
cence is the connective tissue, the presence of collagen and of elastin. Fluorescent
products related to the aging of the cell are lipofuscins and porphyrins.
Figure 5.1: a) Excitation and b) emission spectra of some of the most common
endogenous fluorophores.
5.2.2 Analysis of plasma autofluorescence
To investigate platelet autofluorescence, PRP and PPP was obtained from a
freshly drawn sample of blood, as described in section 2.3. PRP and PPP are
diluted in HEPES buffer according to the concentration required for the analysis.
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Absorbance spectra of PPP and PRP in figure 5.2, collected using a UV-VIS
spectrometer, show a non-zero absorbance of the plasma over all the visible region.
In relation to the analysis shown in section 4.3.2, where the platelet samples la-
Figure 5.2: Normalized absorption spectra of platelet poor plasma (PPP) diluted
4 times in HEPES buffer, and of platelet rich plasma (PRP) diluted 8 times in
HEPES buffer.
belled with anti-GPIX-FITC and with NIR664 NPs-anti-CD41 were excited with
excitation wavelengths of 488 nm and of 633 nm, it can be seen that at those
wavelengths the absorption of the plasma is significant, especially for excitation at
488 nm.
To measure the fluorescence of the plasma in solution, samples were monitored
over time, to see if there is any relation between the aging of the sample and the
magnitude of the fluorescence signal.
Fluorescence spectra were recorded for the PPP upon excitation at wavelengths
488 nm and 633 nm, as shown in figure 5.3. In general it can be seen that PPP
has a peak in the fluorescence at 510 nm, and a smaller shoulder around 580 nm,
when excited at 488 nm. Upon excitation at 633 nm, no clear fluorescence peaks
are present. Interestingly there seems to be a recovery of the fluorescence 2 days
after the sample was taken. Plotting the fluorescence intensity value of figure 5.3
(recorded at 580 nm for graph a) and at 680 nm for graph b)) versus the time in
which the measurement took place after the blood drawing, it can be seen that the
values remain almost constant on the day of the measurement, and increase after
a few days. This is perhaps due to the production of same aging products (figure
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(a) (b)
Figure 5.3: Fluorescence emission spectra of PPP at different times after the blood
has been extracted, upon excitation with a) a 488 nm light, b) a 633 nm light.
5.4). The same experiment repeated using PRP diluted 8 times in HEPES buffer
(a) (b)
Figure 5.4: Fluorescence intensity of PPP a) with 488 nm excitation, monitored
at 580 nm; b) with 633 nm excitation, monitored at 680 nm.
produces the results shown in figure 5.5. The fluorescence spectra recorded after
excitation at 488 nm and at 633 nm remain almost constant over time.
To see if there is any correlation between the aging time of the sample and the
fluorescence intensity, the intensity value at 580 nm (for λexc = 488 nm) and at
680 nm (for λexc = 633 nm) are plotted against time (figure 5.6). From these plots,
no clear behavior is observed and the fluorescence recovery found in the analysis
of PPP is no longer present. Variation in the fluorescence intensity for long times
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(a) (b)
Figure 5.5: Fluorescence emission spectra of PRP excited with a) a 488 nm light,
b) a 633 nm light, at different times after the blood has been extracted.
(a) (b)
Figure 5.6: Fluorescence intensity of PRP a) after 488 nm excitation, monitored
at 580 nm; b) after 633 nm excitation, monitored at 680 nm.
could be due to contamination of the sample or to the presence of some molecules
degrading over time. The fluorescence recovery for PPP can be due to some plasma
protein and not to platelet themselves. In fact, the sample of PRP contains less
plasma proteins than the PPP sample, since it is more diluted compared to PPP,
in order to have an absorbance suitable for fluorescence analysis.
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5.2.3 Analysis of single platelet autofluorescence
Fluorescence measurements with a spectrofluorometer are bulk measurements.
It involves measuring the fluorescence of a cuvette of plasma which averages over
all the platelets as well as over all the other plasma components. To analyze
single platelets one at a time, samples are prepared as follow: PRP is obtained
as described in section 2.3. The plasma is then diluted 1:3 in HEPES buffer
and left for incubation on a glass slide for 45 minutes in static conditions. After
the incubation time, the coverslip is washed 3 times with HEPES buffer and was
fixed with glutaraldehyde for 30 minutes. Glutaraldedhyde is a fixative known to
increase the autofluorescence [53] (for more details see section 2.2). After fixation,
the sample is washed 3 times with PBS and the coverslip mounted on a microscopy
glass slide. The protocol for immobilization of platelets on glass is illustrated in
more detail in section 4.2.1.
Samples were then analyzed with confocal microscopy. An argon laser is used
to excite the specimen at 488 nm and the various wavelength regions of the fluores-
cence signal are spectrally separated. A slit placed in front of the detector allows
the collection of a fluorescence image for each of the wavelengths between 513 nm
and 673 nm in steps of ≈ 10 nm. In figure 5.7 it is shown a composition of 16
fluorescence images color coded according to the emission wavelength intervals. All
these images are then combined together in a single image. In this way it is possible
to see which components of the specimen have a higher signal in a certain region of
the spectrum compared to others. As it can be seen from figure 5.7, there are some
components/granules inside the platelet that have a high fluorescence contribution
in the green part of the spectrum. The outline of the platelet is manually drawn
over the image and the average fluorescence of the pixels enclosed in this region
of interest (ROI) is plotted versus emission wavelength. In this way it is possible
to obtain a fluorescence spectrum of a single platelet. The spectrum obtained for
figure 5.7 is shown in figure 5.8. This spectrum is significantly different from the
one obtained using a spectrofluorometer for a bulk sample of plasma (figure 5.5).
Here it can be seen that a platelet mainly fluoresces in the green region, with a
peak around 555 nm and a shoulder at 540 nm and that there are also some less
intense peaks around 610 and 645 nm (red region of the visible spectrum). The
fluorescence peaks for this platelet is characteristic for all the platelets. Similar
spectra are obtained from single platelets, clumps of platelets and from platelets
with different morphologies. In figure 5.9 several autofluorescence spectra of dif-
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Figure 5.7: Composition of 16 images collected from 513 nm to 673 nm in steps
of ≈ 10 nm for a platelet immobilized on a glass slide. Color coding is associated
with the emission wavelengths.
Figure 5.8: Average fluorescence of the ROI of figure 5.7 versus central wave-
length at which the image is collected. The original data points are fitted with a
polynomial (shown).
ferent platelets are plotted under the same conditions: same microscope settings
(scan time, frame average, zoom, detector gain,...), same sample and same focal
position on zeta axis. To standardize the analysis to screen platelets, the chosen
ROIs are all circles of radius 5 pixels centered in the middle of the platelet. The
peak magnitudes are actually not related to the visual appearance of the platelet,
but to the intracellular contents. As can be seen in figure 5.7 there are some sub-
cellular features that have a different fluorescence emission compared to the rest
of the platelet.
Figure 5.10 compares the average fluorescence of small ROIs inside the same
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Figure 5.9: Fluorescence spectra for various platelets, collected and processed as
described in the text.
platelet. The ROIs are circles of radius 2 pixels, and are distributed all along the y
axis and numbered from 1 to 7 from upper to lower. In figure 5.10b is plotted the
average fluorescence of a ROI relative to the emission around a certain wavelength
versus the ROI number. It can be seen that different regions inside the platelet
contribute more or less to specific emission wavelengths. ROI number 6, placed
almost at the platelet membrane, has a higher contribution at 556 nm compared
to the other ROIs, while having an integrated fluorescence lower or equal to the
other ROIs for the other emission wavelengths. This behavior is not seen for the
other peripheral ROIs of figure 5.10. ROI number 4, placed in the center of the
platelet, has a lower fluorescence emission compared to the adjacent ROIs for all
the wavelengths analyzed. All these data and observations are strictly related to
the platelet content itself and cannot be predicted just by looking at the platelet
shape or condition.
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(a) (b)
Figure 5.10: a) Composition of 16 images collected from 513 nm to 673 nm in steps
of ≈10 nm for a platelet immobilized on a glass slide. Color coding is associated
with the emission wavelengths. b) Fluorescence emission of the ROI of figure a),
versus ROI number, as explained in the text.
5.2.4 Summary of results
From the analysis in this section it is clear that platelet autofluorescence is a
signal that cannot be neglected when developing a fluorescence assay for specific
human platelet disease states. The limit of detection of an assay is strictly related
to the background of the quantity measured. For a platelet assay, the autofluores-
cence is a non-removable background. Spectral analysis of bulk samples of plasma
and of single platelets immobilized on glass did not show any correlation between
the autofluorescence signal and characteristics like sample aging time, platelet
shape and the platelet local environment. From the spectral analysis obtained
using a confocal laser scanning microscope, it is clear that the autofluorescence
signal is not uniform over the platelet and that different intra-cellular components
have different fluorescence properties that cannot be predicted.
5.3 Fluorescence labelling of platelets
5.3.1 Antibody sandwich assays
Using the techniques of platelet immobilization on surfaces described in section
4.2, standard double antibody sandwich assays have been performed. The assays
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have been performed to investigate if the immobilization protocols are suitable for
targeting the platelet receptor αIIbβ3, which is the same receptor that needs to
be targeted for the NP assay.
The primary antibody used is anti-CD41 mouse anti-human and the secondary
is an IgG goat anti-mouse conjugated to the fluorophore Alexa488. The secondary
antibody is added in a second step to bind to the primary antibody. When the
sandwich assay is successful, the platelet membrane is fluorescently labelled with
the Alexa488 fluorophore.
Samples are prepared as follow: platelets, immobilized either on glass either
on fibrinogen printed pattern, are fixed with PFA 3.7 % (w/v) and subsequently
incubated with a 200 µl solution of anti-CD41 in the ratio 1:1000 V:V in PBS
for one hour on the coverslip at room temperature and in static conditions. The
secondary antibody solution is diluted in PBS in a total volume ratio of 1:500 with
the addition of 1.5 % (v/v) of goat serum. After the coverslip has been washed
three times with PBS, a 200 µl drop of the secondary antibody solution is left on
the glass in incubation for 30 minutes in static conditions and room temperature
and then washed again three times with PBS. Afeterwards the coverslip can then
be mounted on a glass slide for microscopy analysis.
The samples are imaged in confocal microscopy, using as excitation light a
488 nm argon laser line. The signal is collected on two separate channels, one
recording the scattering information (using a band pass filter 465-510 nm) and the
other recording the fluorescence (with a low pass filter 505 nm). The two signals are
directed to the detectors using a dichroic glass 490 nm and the pin-hole aperture
is set at 1 Airy unit for both of the channels for optimal optical sectioning. The
scattering channel is used as a reference to identify the platelet position on the
coverslip.
Platelets immobilized on glass
In figure 5.11 is shown the result of a double antibody sandwich assay of undi-
luted PRP immobilized on glass. The platelet membrane is homogeneously
stained with the two antibodies, showing clearly the morphology of the platelets.
When analyzing the samples in confocal microscopy the focus can be set to visu-
alize the different areas of the membrane, like the bottom surface of the platelets
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(a) (b)
(c)
Figure 5.11: Fluorescence image relative to the emission of Alexa488 for a dou-
ble antibody sandwich assay using anti-CD41 as primary antibody. Platelets are
immobilized on the glass slide after 30 minutes incubation and 30 minutes PFA
fixation. In a) is shown an optical section along the z axis at the glass surface,
in b) 1 µm above the glass surface and in c) 2 µm above the glass surface. The
optical sections have a thickness of ≈ 0.8 µm.
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(a)
(b)
Figure 5.12: Control sample of the same assay described previously with using only
the secondary (fluorescent) antibody. The platelets are visible in the scattering
channel (left side) but not present any fluorescence (right side). No fluorescence is
seen when moving the focus from the glass surface (top figures) to µm above the
glass surface (bottom figures).
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that is in contact with the glass (figure 5.11a), or the pseudopodia and filaments
connecting platelets (figure 5.11b) or the upper section of the platelet membrane
(figure 5.11c).
The control experiment in which only the secondary antibody is used presents
no fluorescence signal, as it can be seen from figure 5.12.
This assay is used over the time of the research to investigate the functionality
of the antibody after different storage times.
Platelets immobilized on fibrinogen patterns
In figure 5.13 is shown the result of a double antibody sandwich assay of
platelets immobilized on a fibrinogen pattern using the technique described in
section 4.2.
The results resemble what has been found for the sandwich assay of platelets
immobilized on glass: a good staining of the platelet membrane and no signal from
the control samples. The immobilization of platelets on fibrinogen micro-printed
pattern is therefore suitable for targeting the platelet receptor αIIbβ3.
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(a) (b)
(c)
Figure 5.13: Fluorescence image relative to the emission of Alexa488 for a double
antibody sandwich assay using anti-CD41 as primary antibody. Platelets are im-
mobilized on the fibrinogen printed glass slide after 30 minutes incubation and 30
minutes PFA fixation. In a) is shown an optical section along the z axis at the
glass surface, in b) 1 µm above the glass surface and in c) 2 µm above the glass
surface. The optical sections have a thickness of ≈ 0.8 µm.
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(a)
(b)
Figure 5.14: Control sample of the same assay described previously using only the
secondary (fluorescent) antibody. The platelets over the cross and droplets-shaped
pattern are well visible in the scattering channel (left side) but the fluorescence
channel (right side) is black. No fluorescence is seen when moving the focus from
the glass surface (top figures) to 1 µm above the glass surface (bottom figures).
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5.3.2 Activation-specific antibodies
Activation-specific platelet antibodies are antibodies that bind to an element on
the platelet that is characteristic of activated platelets only. In this experiment an
antibody towards the molecule P-Selectin is used, which is stored in the granules of
platelets and is rapidly transported to the plasma membrane upon activation (see
also section 1.2.1). The aim of the experiment is to explore how the immobilization
of platelets on micro-patterned proteins influence their activation and behavior.
Two different kinds of surfaces have been employed. The first one consists of
fibrinogen printed in patterns of circles with diameter spanning from 2 µm to 24
µm, which is produced as described in section 4.2.2. The second type of surface
has the same pattern but it is composed of anti-CD42b antibodies. These last
plates are prepared by our partner in RCSI.
The reason why these surfaces are compared is because platelets are in two dif-
ferent states when immobilized on fibrinogen or on anti-CD42b [56]. Fibrinogen,
binding to the αIIbβ3 platelet receptor, induces activation of the platelets, while
anti-CD42b targets the GPIbα receptor which is not involved in platelet activation
and therefore induces none or less activation of the platelets [56].
The analysis is targeted only to the platelets confined in the 6 µm spots in
order to exploit best the potential of these micro-printed surfaces. Nowadays
the majority of the studies focus on large groups of platelets. With the protein
micro-pattering technology it is possible to explore what happens in constrained
situations when platelets have just a small area to adhere to (as could happen in
normal haemostasis, when just a small portion of endothelium is damaged). The
current technology of surface patterning still does not permit the analysis of single
platelets only. Single platelets are generally found on the 2 µm spots, but platelet
adherence on these areas is too low to allow a statistically significant analysis.
The samples are prepared by adding the blood over the printed surfaces and
leaving it in incubation for half an hour on a rocking table. The surfaces are then
rinsed three times with HEPES buffer and fixed with PFA 3.7 % (w/v) . After
fixation the coverslips are imaged with atomic force microscopy (AFM results will
be shown in section 5.4). Subsequently the same slides are labelled with CD62P
mouse anti-human conjugated to R-PE (R-Phycoerythrin) dye. This antibody
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binds to P-selectin and it is fluorescently conjugated to a green emitting dye that
can be excited with a argon 488 nm line (see its spectra in figure 5.15). As a
reference a mouse anti-human CD41 antibody, which binds to the receptor αIIbβ3
presents on platelets surface is used. On top of the anti-CD41 is added a goat
anti-mouse IgG antibody conjugated to Alexa Fluor 647. This fluorophore emits
in the near infra-red region of the spectrum (see again figure 5.15) and can be
excited with a helium-neon 633 nm laser line.
(a) (b)
Figure 5.15: Spectral characteristics of the two dyes used for platelet labelling. a)
Normalized excitation (black curve) and emission (red curve) spectra for R-PE. b)
Normalized excitation (dashed curve) and emission (solid curve) spectra for Alexa
Fluor 647 conjugated to IgG, with overimposed the excitation line at 633 nm (red
line).
For each of the samples, three signals have been detected and recorded through
confocal microscopy. These signals are summarized in table 5.1 together with the
setup details.
The fluorescence signal arising from labelled P-selectin is mainly found in the
inner of the platelets, instead the signal from anti-CD41 is more intense from the
outer membrane, as can be seen in figure 5.16. This can be better visualized in the
RGB merging of channel 1 and 2, displayed in figure 5.17. Note also that for both
of the pictures, the focus is placed at the bottom of the slide, as will be explained
later. The two fluorescence signals are not colocalized, as shown by the colocaliza-
tion scatterplots (figure 5.18). For platelets immobilized on fibrinogen there is a
predominance of signal from regions with high contents of anti-P-selectin and low
contents of anti-CD41.
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Signal Source λexc Dichroic Filter Antibody Relative to
Ch0
back reflected
488 490
BP
/ “objects”
scattering light 465-510
Ch1
green
R-PE 488 490 LP 505 anti-CD62P P-selectin
fluorescence
Ch2
NIR Alexa
633 545 LP 650 anti-CD41 αIIbβ3
fluorescence Fluor 647
Table 5.1: Recorded signals and specification of the microscope setup.
(a) Ch1 (b) Ch2
Figure 5.16: Fluorescence image of platelets from WB captured on fibrinogen 6
µm spots, a) from labelled P-selecting (green fluorescence) and b) from labelled
αIIbβ3 (NIR fluorescence).
On anti-CD42b patterned surfaces the fluorescence information collected is sig-
nificantly different, being the NIR fluorescence of labelled αIIbβ3 more dominant
than the green signal of P-selectin events. In the colocalization scatterplots (figure
5.19) the main stripe is not anymore vertical but lays initially over the bisector
and then binds horizontally.
A numerical analysis of the fluorescence intensity was also performed, as de-
101
(a) (b)
Figure 5.17: a) RGB image composition of pictures in figure 5.16 and b) a zoom
of a single 6 µm spot. Ch1 is coded in green and Ch2 in red.
(a) (b)
Figure 5.18: Color (a) and density (b) colocalization scatterplots of the image
in figure 5.16 of platelets on fibrinogen. Ch1 is relative to fluorescence of anti-
P-selectin (labelled in green), Ch2 is from fluorescence of anti-CD41 (labelled in
red).
scribed next.
Ch0, back scattered light, is used to identify the platelets and to create a mask to
isolate the 6 µm circular spots. This channel is also used to set the focus for the im-
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(a) (b)
Figure 5.19: Color (a) and density (b) colocalization scatterplots for platelets on
anti-CD42b patterned 6 µm spots. Ch1 is relative to fluorescence of anti-P-selectin
(labelled in green), Ch2 is from fluorescence of anti-CD41 (labelled in red).
ages collected in Ch1 and Ch2. In this way, between different slides, the z-position
of the objective is relative and instead the focus is controllable and reproducible.
The focus is always placed at the interface between the glass and the bottom of
the platelets (see figure 5.20). The mask is created through an algorithm involving
Figure 5.20: Back scatter image (Ch0) of platelets from WB captured on fibrinogen
6 µm circular spots. Platelets can easily be seen in backscattered light and so the
image can be used to create a mask to locate the platelets.
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the enhancement of contrast, the homogenization of the signal of local areas, the
suppression of the background and the setting of a signal threshold (neglecting
small sized areas). The mask so created identifies most of the platelet 6 µm spots,
losing the ones located at the right-bottom border of the image, where the signal
is hugely compromised by the tilting of the glass. This mask can be applied to
any of the channels, as shown in figure 5.21. The mask was superimposed on a
Figure 5.21: Ch1 green fluorescence channel with superimposed the mask which
was created from the Ch0 back scattering (see also figure 5.20). Deleted ROIs
are ROIs over unoccupied spots (like 54), ROIs overlapping platelets outside from
the pattern (like 11), ROIs overlapping more than 1 spot (like 20), and ROI not
completely overlapping a spot (like 52).
channel to manually remove the errors in the mask: the ROIs not overlapping to
a platelet filled 6 µm spot are deleted. These errors arise from the recognition of
the mask of the scattering of fibrinogen of unoccupied spots or from non-specific
attachment of platelets outside the pattern.
For each of the ROIs is calculated the fluorescence intensity averaged over
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the spot area, obtaining the “pixel fluorescence density” (ρfluo) of a single 6 µm
spot. Table 5.2 summarize the results obtained when averaging ρfluo over more
than 800 ROIs and the standard deviations (σ). The values obtained confirm a
FIBRINOGEN ANTI-CD42b
SURFACE SURFACE
ρfluo σ ρfluo σ
[au/pixel] [au/pixel] [au/pixel] [au/pixel]
P-selectin
783 170 443 45
events
αIIbβ3
529 194 519 89
events
Table 5.2: Pixel fluorescence density for platelets immobilized on 6 µm spots of
two different surfaces. The displayed values are an average of over 800 spots.
larger presence of the activator product P-selectin for platelets immobilized on
fibrinogen, as expected. Fibrinogen is in fact a molecule involved in the activation
process of platelets. For platelets immobilized on 6 µm fibrinogen spots the ratio
of ρfluo from P-selectin events and from αIIbβ3 events is 1.48. For platelets immo-
bilized on 6 µm anti-CD42b spots the ratio is 0.85, below one. It can therefore be
assumed that anti-CD42b micro-printed surfaces activate the platelets less than
fibrinogen surfaces do. Nonetheless, assumptions regarding the degree of activa-
tion of platelets cannot be made. A percentage of the fluorescence from P-selectin
could have been relative to some degree of penetration of the antibody within the
platelet. The permeability of the membrane could in fact be increased by the us-
age of the fixative PFA which is needed for the slide preparation for AFM analysis.
Other experiments are performed introducing an activator at the time of platelet
incubation. The glass slides were prepared, as previously described, printing fib-
rinogen in circular patterns on a glass and blocking the rest of the surface with
BSA. Straight after putting the whole blood on the surface, adenosine diphosphate
(ADP) is added as activator for a final concentration of 1 µM. The glass slide is
then left in incubation for half-an-hour, washed and then stained with antibodies
towards αIIbβ3 and P-Selectin, as previously described.
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The slides so obtained present less adhesion compared to slides prepared with-
out the activator. From the scattering channel Ch0 (figure 5.22) can be seen the
unoccupied spots, since the fibrinogen circles are visible (lighter gray periodical
spots). From the analysis of the fluorescence of platelets confined in the 6 µm
Figure 5.22: Scattering channel of platelets from WB treated with 1 µM ADP
captured on fibrinogen patterned 6 µm spots. 35% of the fibrinogen spots are
unoccupied.
spots it transpires that the value found for the pixel fluorescence density from P-
selectin labelled antibody is still higher than the one from αIIbβ3 (see table 5.3),
with ratio of the two 1.48.
The colocalization analysis of these samples is interesting. An example is shown
in picture 5.23. The signal is still mainly distributed on the left side of the scat-
terplot, showing a predominance of signal from regions with high contents of anti-
CD62P and low contents of anti-CD41, as seen before for the fibrinogen surfaces
with untreated platelets, but also with a small contribution from regions with low
anti-CD62P and high anti-CD41.
The introduction of an activator to the blood has minor influences on the results
obtained, which in fact resemble the one obtained when no activator is used. The
main difference is the level of adhesion that is diminished to around 50% in some
plates.
After an exchange of opinion with our partner in RCSI we suggest that this
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FIBRINOGEN SURFACE
with added ADP
ρfluo σ
[au/pixel] [au/pixel]
P-selectin
480 107
events
αIIbβ3
325 99
events
Table 5.3: Pixel fluorescence density for platelets immobilized on 6 µm fibrinogen
spots. ADP was added at the time of blood incubation. The displayed values are
an average of over 600 spots.
(a) (b)
Figure 5.23: Color (a) and density (b) colocalization scatterplots for platelets
treated with ADP on fibrinogen. Ch1 is relative to fluorescence of anti-P-selectin
(labelled in green), Ch2 is from fluorescence of anti-CD41 (labelled in red). Notice
the bottom stripe of low intensity P-selectin events.
way of sample preparation can perhaps select a subpopulation of platelets. The
scenario could be that platelets reacting to the activator upon its introduction
become activated and recruit other platelets to which they bind, creating a cluster
in the blood and not being able to adhere anymore to the 6 µm spots and maybe
preferring bigger surface areas or no surfaces at all. The presence of a dim low
stripe on the colocalization scatterplots could be related to this subpopulation
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selection. Of course the situation can be more complex, involving factors like the
age of the platelets, their responsiveness and many others.
This is indeed a new interesting topic encountered in this study, and it would
be fascinating to study it to see if it could be used as a tool to discriminate some
platelets from others. Additional experiments with others activators, as TRAP,
should also be performed in both WB and PRP to ensure consistency of the re-
sults obtained. ADP in fact causes only minimal activation to the platelets when
inserted to WB samples, since red blood cells contain a very active uptake system
to remove plasma ADP (to prevent unwanted platelet activation in intact blood
vessels).
5.3.3 Summary of results
Platelets immobilized on glass or protein patterns can be efficiently labelled
with fluorescent antibodies. The use of activation specific antibodies allows to
monitor the state of the platelets and reveal the effects that different kind of
surfaces have on platelets.
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5.4 High resolution morphological studies
5.4.1 Introduction
In this chapter was presented a series of experiments and analysis on platelets
having as a main common topic the use of fluorescence as a signal. It was shown
how to make platelets adhere to different kinds of surfaces, the platelet fluorescence
properties were described , staining of platelets with antibodies was described and
the information provided by staining platelets with activation-specific antibodies
was discussed. From all these topics a particular interest emerged in knowing more
about their morphology and topology.
As already discussed in section 5.3.2 most of recent studies are about large
groups of platelets, either in bulk conditions when analyzing samples of plasma in
a cuvette (like in aggregometry measurements), or depositing a layer of platelets
on a large surface area. A typical scenario is like the one shown in figure 5.24,
where a group of platelets are deposited on a large area of fibrinogen.
(a) (b)
Figure 5.24: AFM image of platelets immobilized on a wide fibrinogen area. a)
height channel, b) 3D projection. Imaged in contact mode in air on dried platelets.
Thanks to the technology of protein printing in micro-patterns described ear-
lier, a powerful tool for the analysis of small groups of platelets in constrained
conditions is now available.
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The data presented in this section are all obtained with AFM. AFM analysis
requires much longer measurement times compared to fluorescence analysis, but it
can image the nanometer-scale features of surfaces. This cannot be obtained with
light based microscopies which are limited by the light diffraction constraints (see
section 2.1.6 for further details about AFM).
The slides employed for the morphological study are the same as have been
presented in section 5.3.2, where the samples are labelled with activation-specific
antibodies and imaged in confocal microscopy. It is important to underline that
the AFM measurements take place before the slides are stained with antibodies, in
order to avoid any interaction between the probe and the antibodies. Samples are
prepared leaving the blood in incubation for half an hour over a protein printed
surface on a rocking table, washing it three times with HEPES buffer and fixing
it with PFA 3.7 % (w/v). Samples are stored in a petri dish containing PBS until
the time of AFM measurement.
At the time of the analysis the coverslip is washed with DI water and dried
under nitrogen. The AFM is then operated in contact mode on dried platelets,
using as a tip a silicon nitride probe with resonance frequency of 65 KHz and force
constant 0.35 N/m.
The morphology data of platelets immobilized on micro-printed protein pat-
terns are compared for two kind of proteins: fibrinogen and anti-CD42b. As already
discussed in section 5.3.2, platelets behave differently when immobilized on fibrino-
gen or on anti-CD42b since the former induces activation on the platelets [56].
5.4.2 Platelets on fibrinogen printed pattern
In this section are presented some of the data collected for platelets immobi-
lized on fibrinogen circular patterns of different sizes.
In figure 5.25 are shown platelets adhering on 12 µm spots. The platelet ad-
herence on the fibrinogen spots is different. In some spots platelets spread all over
the fibrinogen area (figure 5.25a) and in some others the fibrinogen coverage is just
partial. In each of the cases can be seen a tendency of attaching to the fibrinogen in
a “fried-egg style”, with the membrane spread in a flat layer of about 30 nm height
and with the rest of the cell organelles collected in a taller point. The example
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(a) (b) (c)
(d) (e) (f)
Figure 5.25: AFM deflection error images of platelets from WB captured on 12
µm fibrinogen spots. The adherence level is different between the spots. Imaged
in contact mode in air on dried platelets with tip speed 12 µm/s.
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of figure 5.25f, in which just two platelets are on the spot and with most of the
fibrinogen unoccupied, was found quite rarely. The most frequent behavior that is
observed is of platelets spreading almost completely on the spot, like in figure 5.26.
Figure 5.26: AFM 3D surface plot for the spot in figure 5.25e.
On the 2 µm spots the occupancy is very low as already seen in the session about
the fluorescence analysis. Figure 5.27 shows a typical overview of a 2 µm patterned
area, where almost no platelets are found, “preferring” instead the larger spots.
Some non-specific attachment outside from the pattern is also present. Figure 5.28
depicts a high-resolution image of the platelet deposited on the spot of figure 5.27
taken with high line sampling and low tip-speed (12 µm/s).
112
Figure 5.27: AFM deflection error image for platelets from WB captured on 2 µm
fibrinogen spots. Platelet adhesion is almost null and too low for any statistically
significant analysis.Imaged in contact mode in air on dried platelets.
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(a) (b)
Figure 5.28: AFM deflection error (a) and 3D surface plot (b) of a platelet on a
2 µm fibrinogen spot (high-resolution zoom of picture 5.27). Imaged in contact
mode in air on dried platelets.
The morphology analysis was mostly focused on the platelets confined in the 6
µm spots. On these larger spots the occupancy is almost 100 %, as can be seen in
figure 5.29 and in 5.32.
On the spots, platelets deposit in groups of more than one, like in 5.31f where 4
or 5 platelets are present, or, more likely, in groups of 2-3 platelets. In figure 5.30d
two platelets are adhering on the same spot in a different way, one being completely
flat and spread over the protein, and the second one globular-shaped on the top of
the first one. Spots with only one platelet are also recognizable, like in figure 5.30a.
The average spot height is around 300 nm, and the minimum is about 150
nm. These spots are characterized by platelets flattening their membrane over the
fibrinogen area, as in the examples shown. At times on the 6 µm spots there are
found aggregates of platelets taller than 480 nm and presenting a globular shape,
like the one of figure 5.33. The height of this agglomerate is 780 nm. The different
degree of spreading and also the large presence of pseudopodia is to be noticed.
The 6 µm circles are also generally fully occupied by the platelets with very few
examples of platelets not spreading completely over the fibrinogen spot like the
ones of figures 5.34b e 5.34d.
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(a)
(b) (c)
Figure 5.29: a) AFM deflection error of platelets from WB captured on 6 µm
fibrinogen spots. b) and c) are the 3D surface plots of the top two spots. Imaged
in contact mode in air on dried platelets with tip speed 12 µm/s.
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(a) (b)
(c) (d)
(e) (f)
Figure 5.30: AFM 3D surface plots of the platelets in figure 5.29 (from the right
top one to the last one).
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(a) (b)
(c) (d)
(e) (f)
Figure 5.31: AFM 3D surface plots of the platelets in figure 5.32.
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Figure 5.32: AFM deflection error of platelets from WB captured on 6 µm fib-
rinogen spots. Imaged in contact mode in air on dried platelets with tip speed 12
µm/s.
(a) (b)
Figure 5.33: AFM deflection error and 3D surface plots of a 780 nm tall aggregate
of platelets from WB captured on a 6 µm fibrinogen spot.
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(a) (b)
(c) (d)
Figure 5.34: AFM deflection error and 3D surface plots of platelets from WB
captured on 6 µm fibrinogen spots and not spreading completely over the fibrinogen
area. Imaged in contact mode in air on dried platelets with tip speed 12 µm/s.
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With the addition of an activator
As already seen in the fluorescence analysis with activation-specific antibodies
(section 5.3.2) a further investigation was performed for samples in which the blood
was pre-activated by adenosine diphosphate (ADP). 1 µM of ADP was added soon
after putting the blood in incubation on the fibrinogen surface.
These slides present a lower platelet occupancy compared to the samples in
which no pre-activation is induced (see figure 5.35).
Figure 5.35: AFM height image of platelets pre-activated with ADP in WB and
captured on 24 µm fibrinogen spots. Occupancy level is low. Imaged in contact
mode in air on dried platelets with tip speed 12 µm/s.
An interesting behaviour was observed for some platelets adhering to the 12
µm spots, as reported in figure 5.36. Platelets connect to each other through their
pseudopia in a chain maintaining their globular shape. The 12 µm spot of figure
5.36a shows a group of 3-4 platelets whose membranes spread flat over the fibrino-
gen area (as seen previously for platelets not pre-activated) and with a connected
chain of globular platelets outside from the fibrinogen pattern. Also in figure 5.36c
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platelets adhering to the fibrinogen are connected to a platelet outside the spot.
(a) (b)
(c) (d)
Figure 5.36: AFM deflection error and 3D surface plots of platelets pre-activated
with ADP in WB and captured on 12 µm spots. Platelets connected to each other
in a chain. Imaged in contact mode in air on dried platelets with tip speed 12
µm/s.
On 6 µm fibrinogen spots the occupancy level is around 60 %, as already shown
in figure 5.22 of the confocal analysis. The morphology of the platelets confined in
these areas does not present significant difference compared to when no activator
is introduced. In figure 5.38 is shown a couple of platelets adhering to the 6 µm
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(a) (b)
Figure 5.37: AFM deflection error and 3D surface plots of platelets pre-activated
with ADP in WB and captured on 6 µm fibrinogen spots. Imaged in contact mode
in air on dried platelets with tip speed 12 µm/s.
spot in a way similar to what we saw in figure 5.30d of non-pre-activated platelets.
Figure 5.38: AFM height image of pre-activated platelets on a 6 µm fibrinogen
spot. (Detail of picture 5.37b).
Other examples of the morphology of pre-activated platelets on 6 µm spots in-
clude groups of more platelets (figure 5.39), groups of one-two platelets spreading
all over the protein (figure 5.40) and groups of platelets not totally covering the
fibrinogen area (figure 5.41).
The results obtained for pre-activated platelets have minor differences to the
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results acquired for platelets without the addition of an activator. Nevertheless
they present few peculiarities which would be interesting to investigate in a spe-
cially designed study (see also the discussion for these surfaces reported at the end
of section 5.3.2).
(a) (b)
(c) (d)
Figure 5.39: Examples of platelets pre-activated with ADP in WB and captured
on 6 µm fibrinogen spots. Platelets adhere on groups of 3-4 platelets. a) and b)
are the AFM deflection error images, and b) and c) their relative 3D surface plots.
Imaged in contact mode in air on dried platelets with tip speed 12 µm/s.
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(a) (b)
(c) (d)
Figure 5.40: Examples of platelets pre-activated with ADP in WB and captured
on 6 µm fibrinogen spots. Single platelets adhere on the spots spreading their
membrane. a) and b) are the AFM deflection error images, and b) and c) their
relative 3D surface plots. Imaged in contact mode in air on dried platelets with
tip speed 12 µm/s.
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(a) (b)
(c) (d)
Figure 5.41: Examples of platelets pre-activated with ADP in WB and captured
on 6 µm fibrinogen spots. Single platelets adhere on the spots partially covering
the fibrinogen area. a) and b) are the AFM deflection error images, and b) and c)
their relative 3D surface plots. Imaged in contact mode in air on dried platelets
with tip speed 12 µm/s.
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5.4.3 Platelets on anti-CD42b printed pattern
The second type of surface investigated was composed of anti-CD42b antibod-
ies printed in the same circular micro-patterns of the previously presented samples.
These surfaces were prepared by our partner in RCSI.
(a) (b)
Figure 5.42: Low resolution overview image of platelets from WB captured on 6
µm anti-CD42b spots. Each of the spot has a group of more than 3 globular-shaped
platelets. a)AFM deflection error and b)3D surface plot. Imaged in contact mode
in air on dried platelets, tip speed = 20 µm/s, samples/line =256 and lines = 256.
Platelets adhere on micro-patterned anti-CD42 spots in a way substantially
different from what is seen on fibrinogen patterns. On 6 µm anti-CD42b spots
platelets do not spread their membrane flat over the patterned area, but instead
retain their globular shape. Moreover the number of platelets per spot is generally
higher, with spots presenting 7 or more platelets.
The average maximum height is 780 nm, significantly greater than the height
of platelets over fibrinogen patterned areas. On anti-CD42b platelets spread less
and have a higher tendency to pile up one over the other.
Rarely is found a spot with the morphology characteristics observed for platelets
on fibrinogen. One of the few example is shown in figure 5.44b where one platelet
spreads its membrane in a thin layer over the spot and a second platelet adheres
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(a) (b)
(c) (d)
Figure 5.43: Examples of platelets from WB captured on 6 µm anti-CD42b spots.
Big groups of platelets are adhering on the spots. The spreading of platelet mem-
branes is low. a) and b) are the AFM deflection error images, and b) and c) their
relative 3D surface plots. Imaged in contact mode in air on dried platelets with
tip speed 12 µm/s.
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(e) (f)
(g) (h)
Figure 5.43: Examples of platelets from WB captured on 6 µm anti-CD42b spots.
Big groups of platelets are adhering on the spots. The spreading of platelet mem-
branes is low. e) and f) are the AFM deflection error images, and g) and h) their
relative 3D surface plots. Imaged in contact mode in air on dried platelets with
tip speed 12 µm/s.
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(i) (j)
(k) (l)
Figure 5.43: Examples of platelets from WB captured on 6 µm anti-CD42b spots.
Big groups of platelets are adhering on the spots. The spreading of platelet mem-
branes is low. i) and j) are the AFM deflection error images, and k) and l) their
relative 3D surface plots. Imaged in contact mode in air on dried platelets with
tip speed 12 µm/s.
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(m) (n)
(o) (p)
Figure 5.43: Examples of platelets from WB captured on 6 µm anti-CD42b spots.
Big groups of platelets are adhering on the spots. The spreading of platelet mem-
branes is low. m) and n) are the AFM deflection error images, and o) and p) their
relative 3D surface plots. Imaged in contact mode in air on dried platelets with
tip speed 12 µm/s.
130
on the top of the first one.
(a)
(b)
Figure 5.44: Platelets from WB captured on 6 µm anti-CD42b pattern showing a
spot with only 1-2 platelets and with spread morphology. a) AFM deflection error
image and b)3D surface plot of the right anti-CD42b spot. Imaged in contact mode
in air on dried platelets with tip speed 12 µm/s.
In the next section (5.4.4) is discussed a numerical comparison of the effects
that the two different surfaces have on immobilized platelets.
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5.4.4 Data comparison
Platelets on fibrinogen micro-printed surfaces adhere in a different way com-
pared to how they adhere on anti-CD42b. As explained in section 5.3.2 fibrinogen
is a molecule included in the activation chain process whereas anti-CD42b targets
a receptor which is not involved in activation.
A numerical analysis was performed on the platelets confined in the 6 µm spots,
which have a high occupancy and a low number of platelets per spot.
One of the most evident differences is that platelets adhere to anti-CD42b
clustering in globular groups, while on fibrinogen there are only a few platelets
spread almost flat. For each of the spots the number of platelets present can be
supposed by looking at the “bumps” in the 3D surface plot. This is a fast and
easy way to estimate, but cannot be the basis of a numerical analysis. A more
reliable way is to calculate the volume of each spot, and build a histogram of
volume frequency.
For each of the spots a 2D height image was plotted and processed to set a
height-threshold under which the glass surface and the fibrinogen/anti-CD42b layer
are located and over which the whole platelet group is located. The volume is then
calculated for only the part of the data over the threshold, i.e. only for a platelet
group. The minimum group volume observed was ≈ 1.6 µm3, found for platelets
immobilized on the fibrinogen pattern. This value was related to a platelet group
assumed to be composed of one single platelet. Taking into consideration this
minimum value, a volume frequency histogram was created with step separation of
2 µm3. Groups of platelets with volume between 1 and 2 µm3 are likely to contain
one platelet only, groups with volume between 3 and 4 µm3 could be composed of
2 platelets, etc.. but no precise assumption on the platelet number per spot can
be actually made. The volume of a platelet varies from platelet to platelet.
The volume frequency histograms for the two surfaces are presented in figure
5.45. The histograms comparison support what was seen visually in the 2D sur-
face plots: on fibrinogen micro-patterns platelets adhere in groups of fewer platelets
(= smaller volumes) compared to the platelet groups immobilized on anti-CD42b
spots.
Besides calculating the volume, the total surface area of the group over the
protein layer, the projected area of the group ( i.e. the area of the surface occupied
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(a) (b)
Figure 5.45: Volume frequency histogram for platelets immobilized on 6 µm spots
a) of fibrinogen and b) of anti-CD42b. On anti-CD42b spots platelets adhere in
groups of high volume (= more platelets per spot) compared to fibrinogen surfaces
where small volumes groups are found.
by the platelets group) and the surface area of the parts of the group exceeding
half height of the group itself (defined later on as “surface area at half height”) are
also calculated for each group of platelets. These data are then averaged over all
the analyzed spots. Figure 5.46 summarizes the data obtained.
In 5.46a it can be seen that groups of platelets on 6 µm anti-CD42b spots have an
average total surface area higher than platelets immobilized in spots of the same
dimensions composed of fibrinogen, being composed of more “bumps” of platelets.
Also the projected surface area is higher, meaning that platelets on anti-CD42b
patterns expand on average more over the patterned spots. The surface area at half
height is, on average, a quarter of the total surface area for platelets on anti-CD42b
and one seventh for platelets on fibrinogen. This is quite understandable when con-
sidering that groups of platelets on fibrinogen are generally shaped as “fried-eggs”,
with the main part of the membranes located in the lower part of the group, while
instead platelets on anti-CD42b collect in groups maintaining their globular shape.
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(a) (b)
Figure 5.46: a) Average of total surface area, projected area and surface area at
half height for groups of platelets confined on 6 µm spots of fibrinogen or of anti-
CD42b. b) Ratio between the average total surface area and the average surface
area at half height.
5.4.5 Summary of results
By using AFM it was possible to investigate the different morphologies that
platelets assume when immobilized on micro-patterns.
• Platelets adhere on fibrinogen patterns by spreading their membrane flat
over the protein in a “fried-egg” style, while they have a globular shape
when the pattern is composed of a molecule that does not induce activation
(anti-CD42b).
• On 6 µm fibrinogen spots, groups are composed of one or few platelets, while
on anti-CD42b spots, groups are always composed of aggregates of more
platelets.
• Platelet groups are higher on anti-CD42b patterns, with bigger volumes and
with bigger average surface area.
These results show that AFM is a valid tool to discriminate platelet morphology
which is related to their activation status.
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Chapter 6
Summary and future work
6.1 Overall summary
Silica NPs were synthesized in which are encapsulated NIR664 dye. The NPs
have been characterized using DLS, TEM, zeta potential and brightness measure-
ment. Spherical NPs of average diameter 90 ± 15 nm were produced with a good
degree of monodispersity. Two different NP-platelet conjugation approaches were
tested but much work has still to be done to maximize the efficiency of NP-antibody
conjugation and of platelet labelling. The compatibility of the NPs with platelets
was investigated using platelet aggregometry test and flow cytometry which in-
dicated that the platelets are not activated in the presence of the NPs. A short
study of platelet autofluorescence was carried out to investigate whether there was
any correlation between spectral properties with platelet characteristics. Although
this investigation is interesting and platelet autofluorescence has not been widely
reported in literature, no direct correlation was found between any aspect of the
fluorescence and the platelet characteristics. However, this study did establish
that, in order to implement the NP-assay, the brightness will need to exceed the
platelet autofluorescence, hence the importance of increasing the NP brightness.
Platelet immobilization protocols were tested and characterized through AFM
and confocal imaging of fluorescence or autofluorescence signals. The achieved
adherence is space controllable by using micro-printed protein patterns which are
regular in shape and homogeneous in thickness. Antibody sandwich assays which
target the platelet receptor GPIIb-IIIa were efficiently performed on platelets im-
mobilized on glass and on protein patterned surfaces. Studies of platelets in con-
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fined micrometer sized areas show the possibility of discerning the platelet activa-
tion state with the use of activation specific antibodies or with AFM investigation
of platelet morphology.
Together these results show both the development of novel high brightness
probes for cell detection and a rapid, highly controllable cell purification technique.
Both of these areas have each yielded new insights into the activation state of
human platelets and together provide the bases of a novel blood platelet diagnostic
platform.
6.2 Future work
• Optimization of NP brightness.
• Development of new protocols for NP-antibody conjugation.
• Optimization of NP-platelet conjugation and elimination of non-specific bind-
ing.
• Deeper understanding of the role of different immobilization surfaces on
platelets.
• A wider study of morphology and fluorescence signal of platelets on micro-
patterned surfaces.
• Achievement of controlled confinement of single platelets only.
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ADP = adenosine diphosphate
AFM = atomic force microscopy
APTES = amino-propyltriethoxysilane
APTMS = (3-aminopropyl)-trimethoxysilane
BCA = bicinchoninic acid
BSA = bovine serum albumine
CD41 = cluster of differentiation 41
CD42b = cluster of differentiation 42b
CD62P = cluster of differentiation 62P
D = diffusion coefficient
DLS = dynamic light scattering
DNA = deoxyribonucleic acid
EDC = 1-Ethyl-3-[3-dimethylaminopropyl]-carbodiimide hydrochloride
FAD = flavin adenine dinucleotide
FITC = fluorescein isothiocyanate
FL1 = fluorescence channel number 1
FL2 = fluorescence channel number 2
FMN = flavin mononucleotide
FS = forward scattering
GP = glycoprotein
HEA = Health Education Authority
HEPES = (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid)
IgG = immunoglobulin G
Ka = acid dissociation constant
LOD = limit of detection
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MPTES = (3-Mercaptopropyl)triethoxysilane
MRI = magnetic resonance imaging
NADPH = nicotinamide adenine dinucleotide phosphate
NIR664 = 4,5-Benzo-5’-(iodoacetaminomethyl)-1’,3,3,3’,3’-pentamethyl-1
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PBS = phosphate buffered saline
PDI = polydispersity index
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PE = R-phycoerythrin
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PMT = photomultiplier tube
PPP = platelet poor plasma
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RCSI = Royal College of Surgeons in Ireland
RGB = red green blue
ROI = region of interest
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SS = side scattering
Sulfo-NHS = N-hydroxysulfosuccinimide
T1 = first triplet excited state
TEM = transmission electron microscopy
TEOS = tetraethyl orthosilicate
THPMP = 3-trihydroxysilyl)propyl methylphosphonate
TRAP = thrombin receptor-activated peptide
UV = ultravioled
vWF = von Willebrand factor
WB = whole blood
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